Hai‐liang Zhu

Hai‐liang Zhu's AcademicInfluence.com Rankings

Hai‐liang Zhu

Chemistry

#3220

World Rank

#4219

Historical Rank

Analytical Chemistry

#114

World Rank

#121

Historical Rank

Inorganic Chemistry

#151

World Rank

#163

Historical Rank

chemistry Degrees

Download Badge

Chemistry

Hai‐liang Zhu's Degrees

PhD Chemistry University of California, Berkeley
Bachelors Chemistry Peking University

Why Is Hai‐liang Zhu Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Hai‐liang Zhu's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Selective fluorescent probes for live-cell monitoring of sulphide. (2011) (450)
1,3,4-Thiadiazole: synthesis, reactions, and applications in medicinal, agricultural, and materials chemistry. (2014) (311)
Synthesis and antimicrobial activities of Schiff bases derived from 5-chloro-salicylaldehyde. (2007) (290)
Synthesis and biological evaluation of pyrazole derivatives containing thiourea skeleton as anticancer agents. (2010) (241)
A fluorescent probe for rapid detection of hydrogen sulfide in blood plasma and brain tissues in mice (2012) (173)
Syntheses, Crystal Structures, and Antibacterial Activities of Four Schiff Base Complexes of Copper and Zinc (2004) (154)
Chaetominine, a cytotoxic alkaloid produced by endophytic Chaetomium sp. IFB-E015. (2006) (152)
Squaramide-catalyzed enantioselective Friedel-Crafts reaction of indoles with imines. (2010) (145)
Hydrogen-bond-mediated cascade reaction involving chalcones: facile synthesis of enantioenriched trisubstituted tetrahydrothiophenes. (2012) (124)
Urea derivatives as anticancer agents. (2009) (118)
Synthesis, crystal structure and urease inhibitory activities of Schiff base metal complexes (2007) (116)
Polyphenols based on isoflavones as inhibitors of Helicobacter pylori urease. (2007) (116)
Synthesis, structure and antibacterial activity of novel 1-(5-substituted-3-substituted-4,5-dihydropyrazol-1-yl)ethanone oxime ester derivatives. (2008) (115)
Synthesis, structure and structure-activity relationship analysis of caffeic acid amides as potential antimicrobials. (2010) (102)
Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents. (2011) (101)
Transition metal complexes (M = Cu, Ni and Mn) of Schiff-base ligands: Syntheses, crystal structures, and inhibitory bioactivities against urease and xanthine oxidase (2007) (100)
Design, synthesis and biological evaluation of thiazolidinone derivatives as potential EGFR and HER-2 kinase inhibitors. (2010) (98)
Solvolthermal Syntheses and Crystal Structures of Three Linear Trinuclear Schiff Base Complexes of Zinc(II) and Cadmium(II) (2004) (95)
Synthesis, biological evaluation, and molecular docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents. (2011) (95)
Synthesis, molecular modeling, and biological evaluation of cinnamic acid metronidazole ester derivatives as novel anticancer agents. (2010) (94)
Clear Ag¿Ag bonds in three silver(I) carboxylate complexes with high cytotoxicity properties (2003) (91)
Synthesis, molecular modeling and biological evaluation of chalcone thiosemicarbazide derivatives as novel anticancer agents. (2011) (90)
Syntheses, Crystal Structures, and Antibacterial Activities of Four Schiff Base Copper(II), Zinc(II), and Cadmium(II) Complexes Derived from 2‐[(2‐Dimethylaminoethylimino)methyl]phenol (2006) (85)
Synthesis, molecular docking and biological evaluation of metronidazole derivatives as potent Helicobacter pylori urease inhibitors. (2009) (84)
Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent. (2013) (83)
Synthesis, antibacterial activities and molecular docking studies of peptide and Schiff bases as targeted antibiotics. (2009) (80)
Novel 1,3,4-oxadiazole thioether derivatives targeting thymidylate synthase as dual anticancer/antimicrobial agents. (2013) (80)
Design, synthesis and molecular modeling of pyrazole-quinoline-pyridine hybrids as a new class of antimicrobial and anticancer agents. (2014) (79)
Synthesis, molecular docking and biological evaluation of Schiff base transition metal complexes as potential urease inhibitors. (2010) (76)
Synthesis and antifungal activity of 1,2,3-triazole phenylhydrazone derivatives. (2015) (76)
Research Progress of Glycyrrhizic Acid on Antiviral Activity. (2019) (76)
Synthesis and antitumor activity of 1,2,4-triazoles having 1,4-benzodioxan fragment as a novel class of potent methionine aminopeptidase type II inhibitors. (2011) (74)
Synthesis, biological evaluation, and molecular docking studies of cinnamic acyl 1,3,4-thiadiazole amide derivatives as novel antitubulin agents. (2012) (74)
Schiff base transition metal complexes as novel inhibitors of xanthine oxidase. (2008) (74)
Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors. (2010) (73)
Synthesis and molecular docking study of novel coumarin derivatives containing 4,5-dihydropyrazole moiety as potential antitumor agents. (2010) (73)
Synthesis and antifungal activity of nicotinamide derivatives as succinate dehydrogenase inhibitors. (2014) (73)
The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors. (2010) (73)
Design, synthesis, and evaluation of novel fluoroquinolone-flavonoid hybrids as potent antibiotics against drug-resistant microorganisms. (2014) (72)
Naphthoquinones: A continuing source for discovery of therapeutic antineoplastic agents (2018) (72)
Synthesis and structure-activity relationships of N-benzyl-N-(X-2-hydroxybenzyl)-N'-phenylureas and thioureas as antitumor agents. (2010) (72)
Synthesis and biological evaluation of novel luteolin derivatives as antibacterial agents. (2009) (71)
Synthesis, biological evaluation, and molecular docking studies of novel 1,3,4-oxadiazole derivatives possessing benzotriazole moiety as FAK inhibitors with anticancer activity. (2013) (70)
1,3,4-Thiadiazole. Synthesis, Reactions, and Applications in Medicinal, Agricultural, and Materials Chemistry (2014) (70)
Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors. (2013) (68)
Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors. (2009) (68)
Synthesis of C(7) modified chrysin derivatives designing to inhibit beta-ketoacyl-acyl carrier protein synthase III (FabH) as antibiotics. (2009) (67)
Molecular docking, kinetics study, and structure-activity relationship analysis of quercetin and its analogous as Helicobacter pylori urease inhibitors. (2012) (66)
Synthesis, biological evaluation, and molecular docking studies of 2-chloropyridine derivatives possessing 1,3,4-oxadiazole moiety as potential antitumor agents. (2010) (66)
FAK inhibitors in Cancer, a patent review (2018) (66)
Tyrosyl-tRNA synthetase inhibitors as antibacterial agents: synthesis, molecular docking and structure-activity relationship analysis of 3-aryl-4-arylaminofuran-2(5H)-ones. (2011) (66)
Synthesis and antiproliferative activity of indolizine derivatives incorporating a cyclopropylcarbonyl group against Hep-G2 cancer cell line. (2010) (65)
Synthesis and antimicrobical evaluation of a novel class of 1,3,4-thiadiazole: derivatives bearing 1,2,4-triazolo[1,5-a]pyrimidine moiety. (2013) (65)
Synthesis, biological evaluation, and molecular modeling of cinnamic acyl sulfonamide derivatives as novel antitubulin agents. (2011) (64)
Fluorescent sensors for the detection of hydrazine in environmental and biological systems: Recent advances and future prospects (2020) (64)
Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives containing benzodioxole as potential anticancer agents. (2013) (61)
Synthesis, biological evaluation, and molecular docking studies of resveratrol derivatives possessing chalcone moiety as potential antitubulin agents. (2011) (60)
Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors. (2013) (60)
Coumarin sulfonamides derivatives as potent and selective COX-2 inhibitors with efficacy in suppressing cancer proliferation and metastasis. (2016) (60)
Recent progress in the development of small-molecule fluorescent probes for the detection of hydrogen peroxide (2019) (59)
Design, synthesis, antifungal, and antioxidant activities of (E)-6-((2-phenylhydrazono)methyl)quinoxaline derivatives. (2014) (58)
Synthesis, characterization, and biological activity of a Schiff-base Zn(II) complex (2009) (54)
A two-dimensional network constructed via 72-membered heart-shaped macrocycles, a copper(II) complex with 1,3,5-tris(imidazol-1-ylmethyl)-2,4,6-trimethylbenzene and diethylenetriamine ligands (1999) (54)
Imaging Dynamic Peroxynitrite Fluxes in Epileptic Brains with a Near‐Infrared Fluorescent Probe (2019) (54)
Structural revision of aspernigrin A, reisolated from Cladosporium herbarum IFB-E002. (2005) (54)
Synthesis, biological evaluation and molecular docking studies of 1,3,4-thiadiazole derivatives containing 1,4-benzodioxan as potential antitumor agents. (2011) (54)
Structure and total synthesis of aspernigerin: a novel cytotoxic endophyte metabolite. (2006) (53)
Influence of ligand backbones and counter ions on structures of helical silver(I) complexes with di-Schiff bases derived from phthalaldehydes and diamine (2000) (53)
The inhibition of xanthine oxidase by the Schiff base zinc(II) complex (2006) (52)
Synthesis, molecular modeling and biological evaluation of dithiocarbamates as novel antitubulin agents. (2010) (51)
Recent progress in the small-molecule fluorescent probes for the detection of sulfur dioxide derivatives (HSO3-/SO32-). (2019) (51)
Design, synthesis and biological evaluation of novel pyrazoline-containing derivatives as potential tubulin assembling inhibitors. (2015) (49)
Design, modification and 3D QSAR studies of novel naphthalin-containing pyrazoline derivatives with/without thiourea skeleton as anticancer agents. (2013) (49)
Amines and oximes derived from deoxybenzoins as Helicobacter pylori urease inhibitors. (2009) (49)
Pyrazole derivatives as antitumor, anti-inflammatory and antibacterial agents. (2013) (49)
Synthesis, antibacterial activities and molecular docking studies of Schiff bases derived from N-(2/4-benzaldehyde-amino) phenyl-N'-phenyl-thiourea. (2011) (48)
Epileptic brain fluorescent imaging reveals apigenin can relieve the myeloperoxidase-mediated oxidative stress and inhibit ferroptosis (2020) (48)
Synthesis, molecular modeling and biological evaluation of N-benzylidene-2-((5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl)thio)acetohydrazide derivatives as potential anticancer agents. (2014) (48)
Design, synthesis, biological evaluation and molecular modeling of 1,3,4-oxadiazoline analogs of combretastatin-A4 as novel antitubulin agents. (2012) (48)
Synthesis and antioxidant activity of novel Mannich base of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan. (2013) (47)
Nanoscale Metal-Organic-Frameworks Coated by Biodegradable Organosilica for pH and Redox Dual Responsive Drug Release and High-Performance Anticancer Therapy. (2019) (46)
Sulfonamides containing coumarin moieties selectively and potently inhibit carbonic anhydrases II and IX: design, synthesis, inhibitory activity and 3D-QSAR analysis. (2013) (46)
Design, synthesis and biological evaluation of pyrazolyl-nitroimidazole derivatives as potential EGFR/HER-2 kinase inhibitors. (2016) (46)
Synthesis, biological evaluation, and molecular docking studies of N,1,3-triphenyl-1H-pyrazole-4-carboxamide derivatives as anticancer agents. (2012) (46)
Design, synthesis and antimicrobial activities of nitroimidazole derivatives containing 1,3,4-oxadiazole scaffold as FabH inhibitors. (2012) (45)
Synthesis, crystal structure and in vitro antibacterial activity of two novel silver(I) complexes (2009) (45)
Absolute configuration of new cytotoxic and other bioactive trichothecene macrolides. (2006) (45)
Resveratrol and its analogues: promising antitumor agents. (2011) (45)
Synthesis of novel hybrids of pyrazole and coumarin as dual inhibitors of COX-2 and 5-LOX. (2017) (44)
Synthesis and biological evaluation of compounds which contain pyrazole, thiazole and naphthalene ring as antitumor agents. (2014) (44)
An Oxygen Self-Sufficient Core-Shell Metal-Organic Framework-Based Smart Nanoplatform for Enhanced Synergistic Chemotherapy and Photodynamic Therapy. (2020) (44)
A Review: The Anti-inflammatory, Anticancer, Antibacterial Properties of Four Kinds of Licorice Flavonoids Isolated from Licorice. (2020) (43)
Synthesis, biological evaluation, and molecular docking studies of novel 1-benzene acyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as potential tubulin polymerization inhibitors. (2015) (43)
Optimization of LpxC Inhibitors for Antibacterial Activity and Cardiovascular Safety (2019) (43)
Synthesis, biological evaluation and molecular docking studies of pyrazole derivatives coupling with a thiourea moiety as novel CDKs inhibitors. (2013) (43)
Design, synthesis and biological evaluation of quinoline amide derivatives as novel VEGFR-2 inhibitors. (2010) (42)
Three transition metal complexes formed with tripodal polyimidazole ligands: synthesis, crystal structures and reactivity toward superoxide (2001) (42)
Synthesis, characterization and in vitro antitumor activity of three organotin(IV) complexes with carbazole ligand (2011) (42)
1,3,4-oxadiazole derivatives as potential biological agents. (2013) (41)
Synthesis, biological evaluation and 3D-QSAR study of novel 4,5-dihydro-1H-pyrazole thiazole derivatives as BRAF(V⁶⁰⁰E) inhibitors. (2015) (41)
Genistein and its synthetic analogs as anticancer agents. (2012) (41)
Novel 3-arylfuran-2(5H)-one-fluoroquinolone hybrid: design, synthesis and evaluation as antibacterial agent. (2014) (41)
Synthesis and antitumor activity of 1,3,4-oxadiazole possessing 1,4-benzodioxan moiety as a novel class of potent methionine aminopeptidase type II inhibitors. (2013) (41)
Schiff's base derivatives bearing nitroimidazole and quinoline nuclei: new class of anticancer agents and potential EGFR tyrosine kinase inhibitors. (2014) (40)
Synthesis and cytotoxic evaluation of a series of resveratrol derivatives modified in C2 position. (2007) (39)
Design, synthesis, and biological evaluation of chalcone oxime derivatives as potential immunosuppressive agents. (2012) (39)
Synthesis, biological evaluation, and molecular docking studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline derivatives as novel anticancer agents. (2012) (39)
Synthesis, structure and antibacterial activity of new 2-(1-(2-(substituted-phenyl)-5-methyloxazol-4-yl)-3-(2-substitued-phenyl)-4,5-dihydro-1H-pyrazol-5-yl)-7-substitued-1,2,3,4-tetrahydroisoquinoline derivatives. (2009) (39)
Design, synthesis and biological evaluation of novel chalcone derivatives as antitubulin agents. (2012) (39)
Design, synthesis and biological evaluation of pyridine acyl sulfonamide derivatives as novel COX-2 inhibitors. (2011) (38)
Synthesis, Characterization, and Antibacterial and Cytotoxic Study of Metal Complexes with Schiff Base Ligands (2008) (38)
Synthesis, crystal structure and antimicrobial activity of deoxybenzoin derivatives from genistein. (2008) (38)
Design, Synthesis and Antitumor Activity of Novel link-bridge and B-Ring Modified Combretastatin A-4 (CA-4) Analogues as Potent Antitubulin Agents (2016) (37)
A BODIPY–coumarin-based selective fluorescent probe for rapidly detecting hydrogen sulfide in blood plasma and living cells (2013) (37)
Design, synthesis and biological evaluation of novel ferrocene-pyrazole derivatives containing nitric oxide donors as COX-2 inhibitors for cancer therapy. (2018) (37)
3-Arylpropionylhydroxamic acid derivatives as Helicobacter pylori urease inhibitors: Synthesis, molecular docking and biological evaluation. (2016) (36)
Polymeric and tetranuclear silver(I) chains encapsulated by a scorpion-like ligand. Synthesis and st (2000) (36)
Syntheses and structures of three two-dimensional silver(I)–hexamethylenetetramine co-ordination polymers with new topological motifs (2001) (36)
Polycyclic aromatic hydrocarbons in surface sediments of the Jialu River (2011) (36)
Design, synthesis and biological evaluation of chrysin long-chain derivatives as potential anticancer agents. (2010) (36)
Advances in pharmacological activities and mechanisms of glycyrrhizic acid. (2019) (36)
Photooxidation degradation of Reactive Brilliant Red K-2BP in aqueous solution by ultraviolet radiation/sodium hypochlorite. (2009) (36)
Synthesis, structure, molecular docking, and structure-activity relationship analysis of enamines: 3-aryl-4-alkylaminofuran-2(5H)-ones as potential antibacterials. (2011) (35)
Design and synthesis of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III (FabH) as potential antibacterial agents. (2010) (35)
Synthesis, structure and structure-activity relationship analysis of 3-tert-butoxycarbonyl-2-arylthiazolidine-4-carboxylic acid derivatives as potential antibacterial agents. (2009) (35)
Design, synthesis and antibacterial activities of vanillic acylhydrazone derivatives as potential β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors. (2012) (35)
A selective fluorescence probe for H2S from biothiols with a significant regioselective turn-on response and its application for H2S detection in living cells and in living Caenorhabditis elegans (2018) (35)
Synthesis, molecular modeling and biological evaluation of 2-(benzylthio)-5-aryloxadiazole derivatives as anti-tumor agents. (2012) (35)
Synthesis of dihydropyrazole sulphonamide derivatives that act as anti-cancer agents through COX-2 inhibition. (2016) (35)
Syntheses and crystal structures of five two-dimensional networks constructed from staircase-like silver(I) thiocyanate chains and bridging polyamines (2001) (34)
Design and synthesis of thiazole derivatives as potent FabH inhibitors with antibacterial activity. (2014) (34)
Metronidazole acid acyl sulfonamide: a novel class of anticancer agents and potential EGFR tyrosine kinase inhibitors. (2011) (34)
Metronidazole–Flavonoid Derivatives as Anti‐Helicobacter pylori Agents with Potent Inhibitory Activity against HPE‐Induced Interleukin‐8 Production by AGS Cells (2007) (34)
Synthesis and antibacterial activities of metal(II) complexes with Schiff bases derived from 3,5-diiodosalicylaldehyde (2009) (34)
Design, synthesis, biological evaluation and molecular modeling of dihydropyrazole sulfonamide derivatives as potential COX-1/COX-2 inhibitors. (2015) (33)
Treatment of simulated wastewater containing Reactive Red 195 by zero-valent iron/activated carbon combined with microwave discharge electrodeless lamp/sodium hypochlorite. (2010) (33)
Discovery of 1H-benzo[d][1,2,3]triazol-1-yl 3,4,5-trimethoxybenzoate as a potential antiproliferative agent by inhibiting histone deacetylase. (2010) (32)
Synthesis, and antibacterial activity of novel 4,5-dihydro-1H-pyrazole derivatives as DNA gyrase inhibitors. (2014) (32)
Novel 2,4,5-trisubstituted oxazole derivatives: synthesis and antiproliferative activity. (2009) (32)
Synthesis, molecular modeling and biological evaluation of guanidine derivatives as novel antitubulin agents. (2010) (32)
Synthesis of some N-alkyl substituted urea derivatives as antibacterial and antifungal agents. (2010) (32)
Discovery of 6-substituted 4-anilinoquinazolines with dioxygenated rings as novel EGFR tyrosine kinase inhibitors. (2012) (31)
Synthesis, biological evaluation, and molecular docking studies of 1,3,4-thiadiazol-2-amide derivatives as novel anticancer agents. (2012) (31)
Design and synthesis of 4,6-substituted-(diaphenylamino)quinazolines as potent EGFR inhibitors with antitumor activity. (2012) (31)
Design, synthesis and structure-activity relationships of antiproliferative 1,3-disubstituted urea derivatives. (2009) (31)
Identification of new shikonin derivatives as STAT3 inhibitors (2017) (30)
Design and synthesis of N-phenylacetyl (sulfonyl) 4,5-dihydropyrazole derivatives as potential antitumor agents. (2011) (30)
Discovery of a series of 1,3,4-oxadiazole-2(3H)-thione derivatives containing piperazine skeleton as potential FAK inhibitors. (2017) (30)
Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory. (2014) (30)
Synthesis, crystal structures and physical properties of two terephthalate-bridged copper(II) and nickel(II) complexes (2001) (30)
Synthesis and molecular docking studies of novel 2-chloro-pyridine derivatives containing flavone moieties as potential antitumor agents. (2010) (30)
Synthesis, molecular docking and biological evaluation of metronidazole derivatives containing piperazine skeleton as potential antibacterial agents. (2014) (30)
Novel nicotinoyl pyrazoline derivates bearing N-methyl indole moiety as antitumor agents: Design, synthesis and evaluation. (2018) (30)
Design, synthesis and antibacterial activity of isatin derivatives as FtsZ inhibitors (2016) (30)
New Method for the Synthesis of a Mononucleating Cyclic Peptide Ligand, Crystal Structures of its Ni, Zn, Cu, and Co Complexes, and Their Inhibitory Bioactivity Against Urease (2007) (29)
Synthesis, Molecular Modeling, and Biological Evaluation of Novel 1, 3‐Diphenyl‐2‐propen‐1‐one Based Pyrazolines as Anti‐inflammatory Agents (2015) (29)
α-Oxo-γ-butyrolactam, N-containing pronucleophile in organocatalytic one-pot assembly of butyrolactam-fused indoloquinolizidines. (2012) (29)
Copper-catalyzed radical reactions of 2-azido-N-arylacrylamides with 1-(trifluoromethyl)-1,2-benziodoxole and 1-azidyl-1,2-benziodoxole. (2016) (29)
Syntheses and Crystal Structures of Three Polymeric Silver(I) Terephthalate Complexes with Organic N-Donor Ligands: [Ag(pren)]2(tp)·2H2O, [Ag(en)][Ag(μ2-tp)]·H2O, and [Ag2(μ4-tp)(apy)2] (2003) (29)
Synthesis, structures and insulin-like activity of oxidovanadium(V) complexes with aroylhydrazones and ethylmaltol mixed-ligands (2015) (28)
Polycyclic aromatic hydrocarbons and ecotoxicological characterization of sediments from the Huaihe River, China. (2011) (28)
Synthesis, Molecular Docking and Biological Evaluation of Glycyrrhizin Analogs as Anticancer Agents Targeting EGFR (2014) (28)
Design, synthesis and biological evaluation of novel (E)-α-benzylsulfonyl chalcone derivatives as potential BRAF inhibitors. (2012) (28)
Synthesis and Biological Evaluation of 1‐Methyl‐1H‐indole–Pyrazoline Hybrids as Potential Tubulin Polymerization Inhibitors (2016) (28)
Synthesis and Cytotoxic Evaluation of a Series of Resveratrol Derivatives (2006) (28)
Fatty acid binding protein (FABP) inhibitors: a patent review (2012-2015) (2016) (27)
Design, synthesis and antibacterial activity studies of thiazole derivatives as potent ecKAS III inhibitors. (2013) (27)
Design, synthesis and antimicrobial activities evaluation of Schiff base derived from secnidazole derivatives as potential FabH inhibitors. (2013) (27)
Schiff's base derivatives bearing nitroimidazole moiety: new class of antibacterial, anticancer agents and potential EGFR tyrosine kinase inhibitors. (2013) (27)
Adsorption of disperse blue 2BLN by microwave activated red mud (2011) (27)
Design, synthesis and molecular modeling of biquinoline-pyridine hybrids as a new class of potential EGFR and HER-2 kinase inhibitors. (2014) (26)
Syntheses, Crystal Structures, and Cytotoxicity Evaluation of two Chain‐like and Diamond‐like Silver(I) Complexes (2003) (26)
Synthesis, biological evaluation and molecular modeling of dihydro-pyrazolyl-thiazolinone derivatives as potential COX-2 inhibitors. (2012) (26)
Synthesis, biological evaluation of novel 4,5-dihydro-2H-pyrazole 2-hydroxyphenyl derivatives as BRAF inhibitors. (2012) (26)
Synthesis of Resveratrol Analogues, and Evaluation of Their Cytotoxic and Xanthine Oxidase Inhibitory Activities (2008) (26)
Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors. (2012) (26)
Synthesis and Cytotoxic Evaluation of Substituted Urea Derivatives as Inhibitors of Human‐Leukemia K562 Cells (2007) (26)
Silver(I) complexes with quinoline based linear multidentate ligands: self-assembly of sulfur-bridged tetrametallotricyclic boxes (2000) (26)
Recent progress in the design principles, sensing mechanisms, and applications of small-molecule probes for nitroreductases (2020) (26)
Design, synthesis and molecular docking of novel bipyrazolyl thiazolone scaffold as a new class of antibacterial agents (2014) (26)
Design and biological evaluation of novel hybrids of 1, 5-diarylpyrazole and Chrysin for selective COX-2 inhibition. (2018) (25)
Synthesis and antimicrobial activities of 7-O-modified genistein derivatives. (2008) (25)
Advance of promising targets and agents against COVID-19 in China (2020) (25)
Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection. (2018) (25)
Design, synthesis and biological evaluation of urea derivatives from o-hydroxybenzylamines and phenylisocyanate as potential FabH inhibitors. (2011) (25)
Detection Methods and Research Progress of Human Serum Albumin (2020) (24)
Design, synthesis, biological evaluation, and molecular modeling study of 4-alkoxyquinazoline derivatives as potential VEGFR2 kinase inhibitors. (2013) (24)
Activation of C-H bonds in nitrones leads to iridium hydrides with antitumor activity. (2013) (24)
Tubulin inhibitors binding to colchicine-site: A Review from 2015 to 2019. (2019) (24)
Derivatives of resveratrol: potential agents in prevention and treatment of cardiovascular disease. (2012) (24)
Nitroimidazoles as anti-tumor agents. (2011) (24)
Synthesis, biological evaluation and molecular docking of benzimidazole grafted benzsulfamide-containing pyrazole ring derivatives as novel tubulin polymerization inhibitors. (2019) (24)
Hypolipidemic activity in Sprague-Dawley rats and constituents of a novel natural vegetable oil from Cornus wilsoniana fruits. (2012) (24)
Synthesis, molecular modeling and biological evaluation of cinnamic acid derivatives with pyrazole moieties as novel anticancer agents (2014) (24)
Synthesis, Structure and Antibacterial Activity of Potent DNA Gyrase Inhibitors: N′-Benzoyl-3-(4-Bromophenyl)-1H-Pyrazole-5-Carbohydrazide Derivatives (2013) (24)
Telomerase inhibitors: a patent review (2010–2015) (2016) (23)
Discovery and molecular modeling of novel 1-indolyl acetate--5-nitroimidazole targeting tubulin polymerization as antiproliferative agents. (2014) (23)
Synthesis, biological evaluation, 3D-QSAR studies of novel aryl-2H-pyrazole derivatives as telomerase inhibitors. (2013) (23)
6,7-Dihydrobenzo[f]benzo[4,5]imidazo[1,2-d][1,4]oxazepine derivatives as selective inhibitors of PI3Kα. (2015) (23)
Discovery and modification of sulfur-containing heterocyclic pyrazoline derivatives as potential novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors. (2012) (23)
Synthesis, Crystal Structures and Magnetic Properties of Two Methoxo-Bridged Dimeric Copper(II) Complexes [Cu 2(APMD)4(μ2-OMe) 2 ]X 2(APMD = 2-aminopyrimidine; X = BF4 or CIO4) (2002) (23)
A fluorescent sensor for discrimination of HSA from BSA through selectivity evolution. (2018) (23)
Synthesis, structure, and structure-activity relationship analysis of enamines as potential antibacterials. (2007) (23)
Design, synthesis and biological evaluation of pyrazolyl-thiazolinone derivatives as potential EGFR and HER-2 kinase inhibitors. (2012) (23)
N-monoarylacetothioureas as potent urease inhibitors: synthesis, SAR, and biological evaluation (2019) (23)
Synthesis of 1H-pyrazolo[1,2-b]phthalazine-5,10-dione derivatives: assessment of their antimicrobial, antituberculosis and antioxidant activity (2016) (22)
Four two-dimensional highly undulating silver(I)–hexamethylenetetramine co-ordination networks containing micropores (2001) (22)
Enamines as novel antibacterials and their structure-activity relationships. (2008) (22)
Syntheses, structures and photoluminescent properties of silver(I) complexes with in situ generated hexahydropyrimidine derivatives (2004) (22)
Synthesis, biological evaluation and molecular docking studies of amide-coupled benzoic nitrogen mustard derivatives as potential antitumor agents. (2010) (22)
Syntheses, structures and urease inhibitory activities of mononuclear cobalt(III) and 1D cobalt(II) complexes with ligands derived from 3-formylsalicylic acid (2009) (22)
Base‐ and Copper‐Catalyzed Intramolecular Cyclization for the Direct Synthesis of Dihydrofurans (2010) (22)
Design, synthesis and biological evaluation of metronidazole-thiazole derivatives as antibacterial inhibitors. (2014) (22)
Synthesis, antimicrobial activity of lamotrigine and its ammonium derivatives (2009) (22)
A small, steady, rapid and selective TICT based fluorescent HSA sensor for pre-clinical diagnosis (2018) (22)
4-alkoxy-3-arylfuran-2(5H)-ones as inhibitors of tyrosyl-tRNA synthetase: synthesis, molecular docking and antibacterial evaluation. (2011) (22)
Facile synthesis of novel benzotriazole derivatives and their antibacterial activities (2011) (22)
Synthesis, molecular docking and biological evaluation of 3-arylfuran-2(5H)-ones as anti-gastric ulcer agent. (2015) (21)
Fluorescent probes for the detection of alkaline phosphatase in biological systems: Recent advances and future prospects (2021) (21)
Design of a 1,8-naphthalimide-based OFF-ON type bioorthogonal reagent for fluorescent imaging in live cells (2019) (21)
Isoliquiritigenin (ISL) and its formulations: potential antitumor agents. (2018) (21)
Synthesis, biological evaluation, and molecular docking studies of 2,6-dinitro-4-(trifluoromethyl)phenoxysalicylaldoxime derivatives as novel antitubulin agents. (2012) (21)
Design, synthesis, biological evaluation and molecular modeling of novel 1,3,4-oxadiazole derivatives based on Vanillic acid as potential immunosuppressive agents. (2012) (21)
Design, synthesis and biological evaluation of novel 5-phenyl-1H-pyrazole derivatives as potential BRAF(V600E) inhibitors. (2014) (20)
Synthesis, biological evaluation and 3D-QSAR studies of novel 4,5-dihydro-1H-pyrazole niacinamide derivatives as BRAF inhibitors. (2012) (20)
Exploration of structure-based on imidazole core as antibacterial agents. (2013) (20)
Synthesis, molecular docking, and activity of Schiff-base copper(II) complex with N-n-butylsalicylaldiminate as Helicobacter pylori urease inhibitor (2011) (20)
Synthesis, biological evaluation and molecular docking studies of novel 2-(1,3,4-oxadiazol-2-ylthio)-1-phenylethanone derivatives. (2012) (20)
Design, biological evaluation and 3D QSAR studies of novel dioxin-containing triaryl pyrazoline derivatives as potential B-Raf inhibitors. (2016) (20)
A class of novel tubulin polymerization inhibitors exert effective anti-tumor activity via mitotic catastrophe. (2019) (20)
Design, synthesis and evaluation of novel diaryl-1,5-diazoles derivatives bearing morpholine as potent dual COX-2/5-LOX inhibitors and antitumor agents. (2019) (20)
1,3,4-Oxadiazole derivatives as potential antitumor agents: discovery, optimization and biological activity valuation (2016) (20)
Synthesis and Cytotoxic Evaluation of a Series of Genistein Derivatives (2006) (20)
Synthesis, Antiproliferative Activity, and Structure–Activity Relationships of 3‐Aryl‐1H‐quinolin‐4‐ones (2008) (19)
Design and synthesis of novel deoxybenzoin derivatives as FabH inhibitors and anti-inflammatory agents. (2010) (19)
Degradation of C.I. Disperse Blue 56 by Ultraviolet Radiation/Sodium Hypochlorite (2009) (19)
Synthesis, structure and magnetic behavior of a di-μ-chloro-di-μ-imidazolato-tetracopper(II) complex with two dinucleating macrocycles (1999) (19)
Synthesis, molecular modeling and structural characterization of vanillin derivatives as antimicrobial agents (2013) (19)
Oxadiazole derivatives containing 1,4-benzodioxan as potential immunosuppressive agents against RAW264.7 cells. (2011) (19)
Strong Silver‐Silver Interactions in Three Silver(I) Carboxylate Complexes with High Cytotoxicity Properties (2005) (19)
Design, modification and 3D QSAR studies of novel 2,3-dihydrobenzo[b][1,4]dioxin-containing 4,5-dihydro-1H-pyrazole derivatives as inhibitors of B-Raf kinase. (2012) (18)
Synthesis, molecular docking and biological evaluation of 1,3,4-oxadiazole derivatives as potential immunosuppressive agents. (2012) (18)
Synthesis, crystal structure, and growth inhibition of human hepatoma cell (HepG2) of polyphenolic compounds based on gallates (2007) (18)
Indole-based, Antiproliferative Agents Targeting Tubulin Polymerization. (2016) (18)
Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis. (2015) (18)
Synthesis, biological evaluation of chrysin derivatives as potential immunosuppressive agents. (2011) (18)
The syntheses, crystal structure and magnetic behavior of μ-imidazolato-dicopper(II) complexes with the dinucleating hexaazamacrocycles (1999) (18)
Neoplaether, a new cytotoxic and antifungal endophyte metabolite from Neoplaconema napellum IFB-E016. (2006) (17)
Synthesis, characterization, and antibacterial activity of two silver(I) compounds with 4-dimethylaminopyridine (2011) (17)
Synthesis and Cytotoxic Evaluation of Novel 7‐O‐Modified Genistein Derivatives (2007) (17)
3-Aryl-4-acyloxyethoxyfuran-2(5H)-ones as inhibitors of tyrosyl-tRNA synthetase: synthesis, molecular docking and antibacterial evaluation. (2013) (17)
Synthesis, biological evaluation and molecular modeling of 1,3,4-thiadiazol-2-amide derivatives as novel antitubulin agents. (2014) (17)
Cu(II) and Co(II) ternary complexes of quinolone antimicrobial drug enoxacin and levofloxacin: structure and biological evaluation (2014) (17)
Synthesis, Antiproliferative Evaluation, and Structure–Activity Relationships of 3‐Arylquinolines (2008) (17)
A turn-on fluorescent sensor for selective detection of hydrazine and its application in Arabidopsis thaliana. (2019) (17)
Synthesis, biological evaluation and 3D-QSAR studies of novel 5-phenyl-1H-pyrazol cinnamamide derivatives as novel antitubulin agents. (2015) (17)
(E)-1,3-diphenyl-1H-pyrazole derivatives containing O-benzyl oxime moiety as potential immunosuppressive agents: Design, synthesis, molecular docking and biological evaluation. (2016) (17)
Design, Synthesis and Biological Evaluation of Benzohydrazide Derivatives Containing Dihydropyrazoles as Potential EGFR Kinase Inhibitors (2016) (17)
A rapid cell-permeating turn-on probe for sensitive and selective detection of sulfite in living cells. (2018) (17)
Synthesis, biological evaluation and molecular docking studies of 3-(1,3-diphenyl-1H-pyrazol-4-yl)-N-phenylacrylamide derivatives as inhibitors of HDAC activity. (2012) (17)
Synthesis, molecular docking and biological evaluation of coumarin derivatives containing piperazine skeleton as potential antibacterial agents. (2014) (16)
Identification of novel B‐RafV600E inhibitors employing FBDD strategy (2017) (16)
Recent advances of p53-MDM2 small molecule inhibitors (2011-present). (2015) (16)
Synthesis, biological evaluation and molecular docking studies of 1,3,4-oxadiazole derivatives as potential immunosuppressive agents. (2012) (16)
A DNA-based nanocarrier for efficient cancer therapy (2020) (16)
Synthesis, biological evaluation and molecular docking of novel 5-phenyl-1H-pyrazol derivatives as potential BRAF(V600E) inhibitors. (2013) (16)
An imidazo[1,5-α]pyridine-derivated fluorescence sensor for rapid and selective detection of sulfite. (2020) (16)
Design, biological evaluation and 3D QSAR studies of novel dioxin-containing pyrazoline derivatives with thiourea skeleton as selective HER-2 inhibitors (2016) (16)
Synthesis, Crystal Structures, Molecular Docking, and Urease Inhibitory Activities of Transition‐Metal Complexes with a 1,2,4‐Triazolecarboxylic Acid Derived Ligand (2015) (16)
Discovery of a series of novel phenylpiperazine derivatives as EGFR TK inhibitors (2015) (16)
The synthesis, structure and SOD-like behaviors of a μ-imidazolato-dicopper(II) complex with a binucleating hexaazamacrocycle (1998) (16)
Synthesis, structure, and biological assay of cinnamic amides as potential EGFR kinase inhibitors (2013) (16)
Tyrosyl-tRNA synthetase inhibitors: a patent review (2017) (16)
The design, synthesis, in vitro biological evaluation and molecular modeling of novel benzenesulfonate derivatives bearing chalcone moieties as potent anti-microtubulin polymerization agents (2015) (15)
Synthesis, characterization and structure-activity relationship analysis of novel depsides as potential antibacterials. (2009) (15)
Vanillin derivatives as the selective small molecule inhibitors of FtsZ (2014) (15)
Synthesis, molecular modeling and biological evaluation of β-ketoacyl-acyl carrier protein synthase III (FabH) as novel antibacterial agents. (2011) (15)
Combined Molecular Docking, 3D‐QSAR, and Pharmacophore Model: Design of Novel Tubulin Polymerization Inhibitors by Binding to Colchicine‐binding Site (2015) (15)
Design and synthesis of 2-styryl of 5-Nitroimidazole derivatives and antimicrobial activities as FabH inhibitors. (2014) (15)
Synthesis, biological evaluation, and molecular docking studies of novel 2-styryl-5-nitroimidazole derivatives containing 1,4-benzodioxan moiety as FAK inhibitors with anticancer activity. (2014) (15)
Aromatic diacylhydrazine derivatives as a new class of polo-like kinase 1 (PLK1) inhibitors. (2014) (15)
The combination of 4-anilinoquinazoline and cinnamic acid: a novel mode of binding to the epidermal growth factor receptor tyrosine kinase. (2011) (15)
Design and synthesis of fluoroacylshikonin as an anticancer agent. (2013) (15)
Synthesis, Structure, and Antibacterial Activity of Novel 5-Arylpyrazole Derivatives (2008) (14)
Syntheses and Crystal Structures of a Pair of Trinuclear Cobalt(II) Complexes with the Cations [Co3L4(APYH)2] and [Co3L4(APY)2] (APY=2‐aminopyridine, L=N‐salicylaldehyde‐2‐iminopyridine) (2005) (14)
Syntheses and Characterizations of Two Novel Silver Polymers from Assembly 5‐Bromosalicylic Acid and 2‐Aminobenzoic Acid, with High Inhibitory Activities against Jack Bean Urease (2006) (14)
Multifunctional Fluorescent Probe for Simultaneously Detecting Microviscosity, Micropolarity, and Carboxylesterases and Its Application in Bioimaging. (2022) (14)
Identification of novel 1‐indolyl acetate‐5‐nitroimidazole derivatives of combretastatin A‐4 as potential tubulin polymerization inhibitors (2017) (14)
Synthesis and biological evaluation of quinoline–imidazole hybrids as potent telomerase inhibitors: a promising class of antitumor agents (2014) (14)
Metronidazole containing pyrazole derivatives potently inhibit tyrosyl‐tRNA synthetase: design, synthesis, and biological evaluation (2016) (14)
Inclusion of methylviologen in symmetrical α,α′,δ,δ′-tetramethyl-cucurbit[6]uril (2012) (14)
Synthesis and antiproliferative activities against Hep-G2 of salicylanide derivatives: potent inhibitors of the epidermal growth factor receptor (EGFR) tyrosine kinase (2011) (14)
Design of novel nicotinamides as potent and selective monoamine oxidase a inhibitors. (2010) (14)
N,N′‐Bis(2‐nitrobenzylidene)ethylenediamine (2005) (14)
Synthesis, molecular docking, and inhibitory activity of a Ni Schiff-base complex against urease (2010) (14)
Synthesis, biological evaluation and molecular docking studies of resveratrol derivatives possessing curcumin moiety as potent antitubulin agents. (2012) (14)
N,N′-Bis(4-nitrobenzylidene)ethane-1,2-diamine (2004) (14)
Discovery of phenylpiperazine derivatives as IGF-1R inhibitor with potent antiproliferative properties in vitro. (2015) (13)
4,5-Dihydropyrazole derivatives containing oxygen-bearing heterocycles as potential telomerase inhibitors with anticancer activity (2014) (13)
A novel indanone-derivated fluorescence sensor for Cysteine detection and biological imaging (2020) (13)
Design, synthesis and biological evaluation of 2-H pyrazole derivatives containing morpholine moieties as highly potent small molecule inhibitors of APC-Asef interaction. (2019) (13)
A dinuclear oxygen‐bridged Schiff base iron(III) complex derived from N,N′‐bis(2‐hydroxybenzylidene)‐1,2‐diaminopropane (2005) (13)
Advances in the researches on the biological activities and inhibitors of phosphatidylinositol 3-kinase. (2014) (13)
Optimization of Substituted 6-Salicyl-4-Anilinoquinazoline Derivatives as Dual EGFR/HER2 Tyrosine Kinase Inhibitors (2013) (13)
Synthesis, crystal structures, molecular docking, and in vitro biological activities evaluation of transition metal complexes with 4-(3,4-dichlorophenyl) piperazine-1-carboxylic acid (2016) (13)
Synthesis and Antimicrobial Activities of Oximes Derived from O‐Benzylhydroxylamine as FabH Inhibitors (2012) (12)
Synthesis, crystal structures, molecular docking and urease inhibitory activity of nickel(II) complexes with 3-pyridinyl-4-amino-5-mercapto-1,2,4-triazole (2014) (12)
Discovery and synthesis of a novel series of potent, selective inhibitors of the PI3Kα: 2-alkyl-chromeno[4,3-c]pyrazol-4(2H)-one derivatives. (2014) (12)
Discovery of novel aminophosphonate derivatives containing pyrazole moiety as potential selective COX-2 inhibitors. (2020) (12)
Discovery of Chromeno[4,3-c]pyrazol-4(2H)-one Containing Carbonyl or Oxime Derivatives as Potential, Selective Inhibitors PI3Kα. (2016) (12)
Synthesis, biological evaluation, and molecular docking studies of pyrazolyl-acylhydrazone derivatives as novel anticancer agents (2014) (12)
Design, synthesis and molecular docking of salicylic acid derivatives containing metronidazole as a new class of antimicrobial agents. (2015) (12)
Syntheses, Crystal Structures and Cytotoxities of Silver (I) Complexes of 2,2′‐Bipyridines and 1,10‐Phenanthroline (2010) (12)
Interspecific Competition between Microcystis aeruginosa and Anabaena flos-aquae from Taihu Lake, China (2014) (12)
A novel Near-Infrared rhodamine-derivated turn-on fluorescence probe for sensing SO32− detection and their bio-imaging in vitro and in vivo (2021) (12)
Synthesis, molecular modeling and biological evaluation of PSB as targeted antibiotics. (2010) (12)
Synthesis and evaluation of N-analogs of 1,2-diarylethane as Helicobacter pylori urease inhibitors. (2015) (12)
Synthesis, structure, and biological evaluation of three Cu(II) and Ni(II) (E)-3-(3,4-dimethoxyphenyl)acrylate complexes with organic diamines as potential urease inhibitors (2013) (12)
Removal of a Toxic Anthraquinone Dye by Combination of Red Mud Coagulation and Ozonation (2009) (12)
Identification of novel 3,5-diarylpyrazoline derivatives containing salicylamide moiety as potential anti-melanoma agents. (2012) (12)
Synthesis and biological evaluation of novel indole derivatives containing sulfonamide scaffold as potential tubulin inhibitor (2016) (11)
Design, synthesis, and biological evaluation of chrysin derivatives as potential FabH inhibitors (2017) (11)
Clinical Evaluation of Serum Tumor Markers in Patients With Advanced-Stage Non-Small Cell Lung Cancer Treated With Palliative Chemotherapy in China (2020) (11)
Design and synthesis of a novel "turn-on" long range measuring fluorescent probe for monitoring endogenous cysteine in living cells and Caenorhabditis elegans. (2021) (11)
Discovery of novel sulfonamide-containing aminophosphonate derivatives as selective COX-2 inhibitors and anti-tumor candidates. (2020) (11)
A quinoxalinone-derivated fluorescence sensor with optimized solubility for cysteine detection and biological imaging (2019) (11)
Synthesis, crystal structures, molecular docking, in vitro monoamine oxidase-B inhibitory activity of transition metal complexes with 2-{4-[bis (4-fluorophenyl)methyl]piperazin-1-yl} acetic acid (2017) (11)
Synthesis, crystal structures, and fluorescent properties of zinc and cadmium(II) complexes with tridentate Schiff bases (2013) (11)
Recent Progress in Small-Molecule Fluorescent Probes for Detecting Mercury Ions (2020) (11)
A novel structure of silver polymer through Na–O bonds with cytotoxicity property (2004) (11)
Dihydropyrazole Derivatives Containing Benzo Oxygen Heterocycle and Sulfonamide Moieties Selectively and Potently Inhibit COX-2: Design, Synthesis, and Anti-Colon Cancer Activity Evaluation (2019) (11)
Monitoring hydrogen polysulfide during ferroptosis with a two-photon fluorescent probe. (2021) (11)
Synthesis, molecular modeling, and biological evaluation of 1,2,4-triazole derivatives containing pyridine as potential anti-tumor agents (2013) (11)
A functional scaffold in marine alkaloid: an anticancer moiety for human. (2013) (11)
Novel metronidazole-sulfonamide derivatives as potent and selective carbonic anhydrase inhibitors: design, synthesis and biology analysis (2014) (11)
Recent advances in reaction-based fluorescent probes for the detection of central nervous system-related pathologies in vivo (2021) (11)
Discovery of novel bacterial FabH inhibitors (Pyrazol-Benzimidazole amide derivatives): Design, synthesis, bioassay, molecular docking and crystal structure determination. (2019) (11)
The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections. (2018) (11)
Syntheses, crystal structures, and cytochrome P450-like hydroxylation property of two novel copper(II) complexes (2005) (11)
Synthesis, Characterization and Crystal Structures of Four Dinuclear Schiff Base Nickel(II) and Copper(II) Complexes with Versatile Bridging Groups (2007) (11)
Synthesis and biological evaluation of Cu(II), Zn(II), and Ni(II) 3-(4-nitrophenyl)acrylic acid complexes with diamines as potential urease inhibitors (2013) (11)
Design, synthesis and biological evaluation of (E)-3-(3,4-dihydroxyphenyl)acrylylpiperazine derivatives as a new class of tubulin polymerization inhibitors. (2014) (11)
Synthesis, biological evaluation, and molecular docking studies of novel chalcone oxime derivatives as potential tubulin polymerization inhibitors (2014) (11)
Synthesis and antimicrobial activities of metal(II) complexes with bis(2,4-diiodo-6-propyliminomethyl-phenol)-pyridine (2009) (10)
Synthesis and Biological Evaluation of Glycyrrhetic Acid Derivatives as Potential VEGFR2 Inhibitors (2017) (10)
Efficient and Highly Enantioselective Michael Addition of Aldehydes to Nitroalkenes Catalyzed by a Surfactant-type Organocatalyst in the Presence of Water (2010) (10)
Synthesis, inhibitory activity and molecular docking studies of two Cu(II) complexes against Helicobacter pylori urease (2012) (10)
Metronidazole–Deoxybenzoin Derivatives as Anti‐Helicobacter pylori Agents with Potent Inhibitory Activity against HPE‐Induced Interleukin‐8 (2010) (10)
Developing potential Helicobacter pylori urease inhibitors from novel oxoindoline derivatives: Synthesis, biological evaluation and in silico study. (2018) (10)
Dihydropyrazoles containing morpholine: design, synthesis and bioassay testing as potent antimicrobial agents (2015) (10)
Synthesis, crystal structure, and urease inhibition studies of copper(II) and cobalt(III) complexes with bi(2-fluorobenzylaminoethyl)amine (2011) (10)
A novel series of benzothiazepine derivatives as tubulin polymerization inhibitors with anti-tumor potency. (2021) (10)
Novel dihydropyrazole derivatives linked with multi(hetero)aromatic ring: Synthesis and antibacterial activity (2009) (10)
Synthesis, structure, urease inhibitory, and cytotoxic activities of two complexes with protocatechuic acid derivative and phenanthroline (2015) (10)
Synthesis and antiproliferative activity of multisubstituted N-fused heterocycles against the Hep-G2 cancer cell line (2011) (10)
Recent Advances in the Design and Synthesis of c-Met Inhibitors as Anticancer Agents (2014-Present). (2017) (10)
Design, Synthesis, and Immunosuppressive Activity of New Deoxybenzoin Derivatives (2010) (10)
Optimization techniques for novel c-Met kinase inhibitors (2018) (10)
Syntheses and Structural Characterization of Four New Silver(I) Complexes with the N,N′(O)‐bidentate Bridging Ligands (2009) (10)
Synthesis and Crystal Structure of 2,4-Diiodo-6-[(2-morpholin-4-yl-ethylimino)-methyl]-phenolato-zinc(II) (2009) (9)
EGFR/HER-2 inhibitors: synthesis, biological evaluation and 3D-QSAR analysis of dihydropyridine-containing thiazolinone derivatives (2015) (9)
Optimization of substituted cinnamic acyl sulfonamide derivatives as tubulin polymerization inhibitors with anticancer activity. (2018) (9)
Synthesis, crystal structures, and biological activity of oxovanadium(V) complexes with similar tridentate hydrazone ligands (2014) (9)
Recent Developments of Metal and Metal Oxide Nanocatalysts in Organic Synthesis. (2016) (9)
Molecular structure and characterization of a pair of hydrate isomers for dinuclear copper(II) complexes with a 26-membered hexaazamacrocycle (1998) (9)
Recent advances of small molecule focal adhesion kinase (FAK) inhibitors as promising anticancer therapeutics. (2021) (9)
Photoreduction of Reactive Brilliant Red X-3B by Ultraviolet Irradiation/Potassium Borohydride/Sodium Bisulfite (2010) (9)
A patent review of RAF kinase inhibitors (2010–2018) (2019) (9)
Degradation of Active Brilliant Red X‐3B by a microwave discharge electrodeless lamp in the presence of activated carbon (2010) (9)
A new selective fluorescence probe with a quinoxalinone structure (QP-1) for cysteine and its application in live-cell imaging. (2018) (9)
Discovery of vinylogous carbamates as a novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors. (2011) (9)
Design, synthesis, biological evaluation and molecular docking of novel metronidazole derivatives as selective and potent JAK3 inhibitors (2014) (9)
Design, synthesis and evaluation of benzenesulfonamide-substituted 1,5-diarylpyrazoles containing phenylacetohydrazide derivatives as COX-1/COX-2 agents against solid tumors (2016) (9)
Novel FabH inhibitors: a patent and article literature review (2000 – 2012) (2012) (9)
Synthesis, structural characterization, molecular docking, and urease inhibition studies of dinuclear cobalt(II) complexes derived from 3,5-bis(pyridin-2-yl)-4-amino-1,2,4-triazole (2014) (9)
Adsorbable Organic Halogens Generation and Reduction During Degradation of Phenol by UV Radiation/Sodium Hypochlorite (2009) (9)
Synthesis, characterization and antibacterial activities of N-tert-butoxycarbonyl-thiazolidine carboxylic acid (2015) (9)
Direct Synthesis of Nitriles from Aldehydes Using Chloramine-T/KI in Aqueous Ammonia (2013) (9)
A dinuclear Schiff base iron(III) complex with the ligand N,N′-bis(2-oxidophenylmethyleneimino)propane-1,2-diamine (2004) (9)
Novel 5‐Methyl‐2‐[(un)substituted phenyl]‐4‐{4,5‐dihydro‐ 3‐[(un)substituted phenyl]‐5‐(1,2,3,4‐tetrahydroisoquinoline‐2‐yl)pyrazol‐1‐yl}‐oxazole Derivatives: Synthesis and Anticancer Activity (2009) (9)
Design, synthesis, and antibacterial evaluation of new Schiff’s base derivatives bearing nitroimidazole and pyrazole nuclei as potent E. coli FabH inhibitors (2015) (9)
Two novel 2D waves copper(II) coordination polymer with the quinolone antimicrobial drugs ciprofloxacin: Synthesis, structure and biological evaluation (2015) (9)
Potentiating 1-(2-hydroxypropyl)-2-styryl-5-nitroimidazole derivatives against antibacterial agents: design, synthesis and biology analysis. (2013) (9)
Discovery of 4,6-substituted-(diaphenylamino)quinazolines as potent c-Src inhibitors. (2013) (9)
Synthesis, biological evaluation and molecular docking studies of novel 1-(4,5-dihydro-1H-pyrazol-1-yl)ethanone-containing 1-methylindol derivatives as potential tubulin assembling inhibitors (2016) (9)
Imaging of formaldehyde fluxes in epileptic brains with a two-photon fluorescence probe. (2020) (9)
Chaetominine, a Cytotoxic Alkaloid Produced by Endophytic Chaetomium sp. IFB‐E015. (2007) (8)
The Research Progress of DPP-4 Inhibitors. (2020) (8)
Recent Research on Methods to Improve Tumor Hypoxia Environment (2020) (8)
Design and biological evaluation of novel triaryl pyrazoline derivatives with dioxane moiety for selective BRAFV600E inhibition. (2018) (8)
Synthesis, structure characterization, and biological evaluation of some new 1,2,3-benzotriazole derivatives (2010) (8)
Synthesis, Molecular Modeling and Biological Evaluation of 4-Alkoxyquinazoline Derivatives as Novel Inhibitors of VEGFR2. (2016) (8)
Novel topological index F based on incidence matrix (2003) (8)
Manganese dioxide (MnO2) based nanomaterials for cancer therapies and theranostics (2020) (8)
Synthesis and antibacterial activities of copper(II) with [(2-hydroxy-3,5-diiodo-benzylidene)-amino]-acetic acid (2010) (8)
Syntheses and Crystal Structures of a Pair of Azide Bridge Copper(II) Complexes with the Cations [Cu2(L1)2(N3)2]2 and [CuL2N3] · 2H2O (L1=N‐3‐carboxyl‐2‐hydroxybenzaldehyde‐ N‐aminoethylmorpholine, L2=N‐salicylaldehyde‐N‐amino ethylmorpholine) (2006) (8)
Synthesis of phenylpiperazine derivatives of 1,4-benzodioxan as selective COX-2 inhibitors and anti-inflammatory agents. (2016) (8)
A Versatile Fluorescent Probe for Simultaneously Detecting Viscosity, Polarity and Nitroreductases and Its Application in Bioimaging (2021) (8)
N-monosubstituted thiosemicarbazide as novel Ure inhibitors: synthesis, biological evaluation and molecular docking. (2020) (8)
Synthesis, crystal structures and in vitro antibacterial activity of two novel organotin(IV) complexes (2011) (8)
Adenosine analogs as inhibitors of tyrosyl-tRNA synthetase: Design, synthesis and antibacterial evaluation. (2015) (8)
Multifunctional fluorescent probes "killing two birds with one stone" - recent progress and outlook (2020) (8)
Efficient Method for the Synthesis of Tectorigenin (2008) (8)
A Quinoline-Based Ratiometric and Reversible Fluorescent Probe for Cadmium Imaging in Living Cells. (2016) (8)
Syntheses, Crystal Structures, Thermal Stability, and Fluorescence Properties of Zinc(II) Complexes With Tridentate Schiff Bases (2013) (8)
Synthesis and evaluation of new tyrosyl-tRNA synthetase inhibitors as antibacterial agents based on a N2-(arylacetyl)glycinanilide scaffold. (2015) (8)
Glycyrrhetic acid monoglucuronide: sweetness concentration–response and molecular mechanism as a naturally high-potency sweetener (2019) (8)
3D-QSAR and Molecular Docking Studies on Benzotriazoles as Antiproliferative Agents and Histone Deacetylase Inhibitors (2013) (8)
Synthesis and crystal structures of a pair of rarely seen isologues (2004) (8)
Synthesis, molecular docking and biological evaluation of 1‐phenylsulphonyl‐2‐(1‐methylindol‐3‐yl)‐benzimidazole derivatives as novel potential tubulin assembling inhibitors (2017) (8)
Design, synthesis, and biological evaluation of new B-RafV600E kinase inhibitors. (2018) (8)
Novel Schiff‐Base‐Derived FabH Inhibitors with Dioxygenated Rings as Antibiotic Agents (2013) (8)
Synthesis and crystal structure of aquo-N-(2-hydroxyphenylmethenylimino)-1, 5-diamine-3-azapentanecopper(II), chloride (2004) (8)
A Systematic Review of the Comparison of Three Medicinal Licorices, Based onDifferences of the Types and Contents about Their Bioactive Components (2018) (8)
Identification, potency evaluation, and mechanism clarification of α-glucosidase inhibitors from tender leaves of Lithocarpus polystachyus Rehd. (2021) (8)
Design, synthesis, evaluation and 3D-QSAR analysis of benzosulfonamide benzenesulfonates as potent and selective inhibitors of MMP-2 (2014) (8)
Development of novel chromeno[4,3-c]pyrazol-4(2H)-one derivates bearing sulfonylpiperazine as antitumor inhibitors targeting PI3Kα. (2019) (8)
A linear trinuclear CoII–CoII–CoII complex with μ-acetate bridges: di-μ-acetato-bis[μ-N,N′-bis(salicylidene)-1,4-butanediaminato]tricobalt(II) (2004) (8)
A fluorescent sensor for selective detection of hypochlorite and its application in Arabidopsis thaliana. (2020) (7)
Degradation of Reactive Brilliant Red X‐3B Dye by Microwave Electrodeless UV Irradiation (2011) (7)
Synthesis, anticancer activity and molecular docking studies on 1,2-diarylbenzimidazole analogues as anti-tubulin agents. (2019) (7)
Covalently immobilize crude d-amino acid transaminase onto UiO-66-NH2 surface for d-Ala biosynthesis. (2021) (7)
Design, synthesis, biological evaluation of benzoyl amide derivatives containing nitrogen heterocyclic ring as potential VEGFR-2 inhibitors. (2019) (7)
A patent review of BRAF inhibitors: 2013-2018 (2019) (7)
Design, synthesis and biological evaluation of novel chromeno[4,3-c]pyrazol-4(2H)-one derivates containing sulfonamido as potential PI3Kα inhibitors. (2019) (7)
Identification of nitroimidazole-oxime derivatives targeting the polo-box domain of polo-like kinase 1. (2017) (7)
Synthesis and Crystal Structure of 4,6-dihydroxy-2-[2-(4-hydroxy-phenyl)-vinyl]-benzene-1,3-dicarbaldehyde (2007) (7)
Dichloro{2-[N-(2-hydroxyethylammonioethyl)iminomethyl]phenolate}zinc(II) (2003) (7)
A selective fluorescent sensor for cysteine detection with potential as a white light emitting fluorophore in living cell imaging (2019) (7)
The Synthesis, Structure and Activity Evaluation of Secnidazole Derivatives as Helicobacter pylori Urease Inhibitors (2011) (7)
Discovery and development of novel rhodanine derivatives targeting enoyl-acyl carrier protein reductase. (2019) (7)
Dibenzoato-di(2-aminopyridine)nickel(II) (2003) (7)
Synthesis, Crystal Structure and Characterization of Two Polymeric Silver(I) Complexes Containing Imidazolate Anions (2005) (7)
A novel fluorescent probe for Hg2+ detection in a wide pH range and its application in living cell imaging (2018) (7)
Synthesis and biological evaluation of novel N, N′-disubstituted urea and thiourea derivatives as potential anti-melanoma agents (2012) (7)
An umbelliferone-derivated fluorescent sensor for selective detection of palladium(II) from palladium(0) in living cells. (2019) (7)
Biotinylated curcumin as a novel chemosensitizer enhances naphthalimide-induced autophagic cell death in breast cancer cells (2021) (7)
2D and 3D Silver(I)-Ethylenediamine Coordination Polymers with Ag–Ag Argentophilic Interactions (2007) (7)
Synthesis and Biological Evaluation of 7-O-Modified Formononetin Derivatives (2008) (7)
Synthesis, Crystal Structure and Immunosuppressive Activity of Acylamide Derivatives Containing 1,4‐Benzodioxan (2009) (7)
Methyl indole‐3‐carboxylate (2005) (7)
Synthesis, crystal structure and property of a novel azide-bridged one-dimensional chain copper(II) complex with a dinucleating macrocyclic polyamine (1999) (7)
Bis(N‐(2‐(2‐hydroxyethylamino)ethyl)salicylideneimine)cobalt(III) chloride (2003) (7)
5-Bromosalicylic acid (2004) (7)
Cyclin-dependent kinase 4/6 inhibitors for cancer therapy: a patent review (2015 – 2019) (2020) (7)
Syntheses, Crystal Structures, Superoxide Dismutase-Like Behaviors and Physical Properties of Four Manganese(III) Complexes with Di-Schiff Bases Derived from Salicylaldehyde and Polyamines (2002) (7)
A novel thiocyanate-bridged dinuclear cadmium(II) complex: di-mu-thiocyanato-bis((methanol){4-nitro-2-[2-(dimethylamino)ethyliminomethyl]phenolato}cadmium(II)). (2005) (7)
Synthesis of novel cinnamanilides as potential immunosuppressive agents. (2012) (7)
Clinical evaluation of plasma coagulation parameters in patients with advanced‐stage non‐small cell lung cancer treated with palliative chemotherapy in China (2020) (7)
Tris[2‐(cyclopropyliminomethyl)phenolato]manganese(III) (2004) (7)
Resolution and evaluation of 3‐chlorophenyl‐3‐hydroxypropionylhydroxamic acid as antivirulence agent with excellent eradication efficacy in Helicobacter pylori infected mice (2018) (6)
Treating Dye Wastewater of Reactive Brilliant Red K-2BP by Cetyltrimethylammonium Chloride- Modified Bentonite with Polyacrylamide Flocculant (2011) (6)
Ni(II) Ternary Complex Based on Antimicrobial Drug Enoxacin: Synthesis and Biological Properties (2014) (6)
Polymeric structure of (ethylenediamine)silver(I) 3-nitrobenzoate monohydrate. (2003) (6)
Design of potent B‐RafV600E inhibitors by multiple copy simulation search strategy (2018) (6)
Discovery of fluoroquinolone derivatives as potent, selective inhibitors of PI3Kγ (2015) (6)
A NIR-triggered multifunctional nanoplatform mediated by Hsp70 siRNA for chemo-hypothermal photothermal synergistic therapy. (2021) (6)
Synthesis, structure, and urease inhibitory activities of three binuclear copper(II) complexes with protocatechuic acid derivative (2014) (6)
2‐(o‐Tolyliminomethyl)phenol (2005) (6)
Synthesis and Biological Evaluation of Novel Aryl-2H-pyrazole Derivatives as Potent Non-purine Xanthine Oxidase Inhibitors. (2015) (6)
Introducing ortho-methoxyl group as a fluorescence-enhancing and bathochromic-shift bi-functional strategy for typical cysteine sensors. (2020) (6)
Di-μ2-acetato-bis[μ2-N,N′-bis(salicylidene)butane-1,4-diaminato]trimanganese(II) (2005) (6)
Discovery of novel indole‐1,2,4‐triazole derivatives as tubulin polymerization inhibitors (2021) (6)
Design, synthesis, and evaluation of substituted 6-amide-4-anilinoquinazoline derivatives as c-Src inhibitors (2013) (6)
The Syntheses and Crystal Structures of Metronidazole-derived Compounds (2008) (6)
Schiff’s base derivatives bearing 2-thiophenoxyquinoline nucleus as new antibacterial agents (2013) (6)
5‐Chloro‐2‐(2‐hydroxybenzylideneamino)benzonitrile (2006) (6)
2-[(E)-2-(4-Hydroxyphenyl)ethyliminomethyl]phenol (2006) (6)
Design, synthesis, and biological evaluation of 2,3‐diphenyl‐cycloalkyl pyrazole derivatives as potential tubulin polymerization inhibitors (2019) (6)
Synthesis and antibacterial evaluation of novel Schiff's base derivatives of nitroimidazole nuclei as potent E. coli FabH inhibitors (2014) (6)
Synthesis and characterization of the complexes of pentane-2,4-dione with nickel(II) and cobalt(III): [Ni(acac)2].0.5CH3OH and [Co(acac)2NO3].2H2O (acac = pentane-2,4-dione). (2004) (6)
Synthesis and Characterization of Ag(I) Salts with Pyridine Derivatives (2005) (6)
Synthesis and Structure-Activity Relationship Analysis of Enamines as Potential Antibacterial Agents (2007) (6)
trans-Diaquabis[4-(4-methylphenyl)-3,5-bis(2-pyridyl)-4H-1,2,4-triazole]nickel(II) diperchlorate tetrahydrate (2004) (6)
Discovery of New 4‐Alkoxyquinazoline‐Based Derivatives as Potent VEGFR2 Inhibitors (2015) (6)
Synthesis and crystal structure of [Co(phen)(H2O)4](SO4)⋅2(H2O) (2004) (6)
Dihydropyrazothiazole derivatives as potential MMP-2/MMP-8 inhibitors for cancer therapy. (2018) (6)
Synthesis, Crystal Structure and Characterization of [Bis { N,N′ -bis(2-aminoethyl) propane-1,3-diamine} (µ- imidazolato-N,N′)dizinc(II)] Triperchlorate (1999) (6)
trans-Bis(isothiocyanato-κN)tetrapyridinecadmium(II) (2004) (5)
A MnO2-coated multivariate Porphyrinic metal-organic frameworks for oxygen self-sufficient chemo-photodynamic synergistic therapy. (2021) (5)
Synthesis, characterization, and biological evaluation of a novel Zn(II)-Naproxen complex (2019) (5)
Synthesis, characterization, and biological activity of a Cu(I) complex with 2-(9H-carbazol-9-yl) acetic acid (2010) (5)
catena-Poly[[silver(I)--ethane-1,2-diamine-? 2 N:N'] 3-fluorobenzoate monohydrate] (2004) (5)
Synthesis and Characterization of Diaquatetra(3,5‐dinitrobenzoato)tetrasilver(I) and Polymeric (Ethylenediaminesilver(I) Di(3,5‐dinitrobenzoato)silver(I) Dihydrate) (2005) (5)
Design of novel N-phenylnicotinamides as selective cyclooxygenase-1 inhibitors. (2011) (5)
Synthesis of α-Aminoalkyl Phosphonate Derivatives of Resveratrol as Potential Antitumour Agents (2008) (5)
Modification, Biological Evaluation and 3D QSAR Studies of Novel 2-(1,3-Diaryl- 4,5-Dihydro-1H-Pyrazol-5-yl)Phenol Derivatives as Inhibitors of B-Raf Kinase (2014) (5)
Design, synthesis and biological evaluation of metronidazole-thiazole derivatives as antibacterial inhibitors. (2014) (5)
Design, synthesis, and biological evaluation of pyrazole derivatives containing acetamide bond as potential BRAFV600E inhibitors. (2018) (5)
URD12: A urea derivative with marked antitumor activities. (2012) (5)
Synthesis, biological evaluation and molecular docking studies of flavone and isoflavone derivatives as a novel class of KSP (kinesin spindle protein) inhibitors. (2013) (5)
The Effect of Solvent on Isomer Formation. Synthesis and Crystal Structures of CdII Complexes with 3-Nitrobenzoate and Thiourea (2002) (5)
Synthesis, Molecular Modeling and Biological Evaluation of 7-Sulfanylflavone as Anticancer Agents (2011) (5)
Syntheses and Crystal Structures of Cobalt(III) and Manganese(III) Complexes With bis-Schiff Bases (2013) (5)
trans‐Bis{2‐[(3‐cyclohexylaminopropylimino)methyl]phenolato}dithiocyanatonickel(II) (2003) (5)
Hydrogen bond and steric effect directed preparation and structures of dioxovanadium(V) complexes with tridentate Schiff bases (2013) (5)
Novel depsides as potential anti-inflammatory agents with potent inhibitory activity against Escherichia coli-induced interleukin-8 production (2010) (5)
Synthesis and Structure-Activity Relationship Studies of N-monosubstituted Aroylthioureas as Urease Inhibitors. (2020) (5)
Design, synthesis and biological evaluation of novel benzo-α-pyrone containing piperazine derivatives as potential BRAFV600E inhibitors. (2016) (5)
Hexaquairon(II) dinitrate bis(dihexamethylenetetramine) tetrahydrate (2003) (5)
Synthesis, crystal structures, molecular docking, and in vitro biological activities of transition metals with 4-(2,3-dichlorophenyl)piperazine-1-carboxylic acid. (2016) (5)
Synthesis of Caffeic Acid Amides Bearing 2,3,4,5-Tetra-hydrobenzo[b][1,4]dioxocine Moieties and Their Biological Evaluation as Antitumor Agents (2014) (5)
Synthesis, crystal structures, and magnetic properties of tetranuclear nickel(II) and copper(II) complexes with tridentate Schiff bases (2013) (5)
Synthesis, Characterization and Bioactivity Research of a Derivative of Secnidazole: 1-(2-Chloropropyl)-2-methyl-5-nitro-1H-imidazole (2011) (5)
Bis(2‐aminopyrimidine)silver(I) trifluoromethanesulfonate hemihydrate (2003) (5)
Synthesis, Crystal Structures and Urease Inhibition of N'-(2-Bromobenzylidene)-2-(4-nitrophenoxy) acetohydrazide and N'-(4-Nitrobenzylidene) -2-(4-nitrophenoxy)acetohydrazide. (2015) (5)
Diaquabis(ethylenediamine-? 2 N,N')copper(II) bis(4-fluorobenzoate) (2004) (5)
Synthesis and evaluation of adenosine containing 3-arylfuran-2(5H)-ones as tyrosyl-tRNA synthetase inhibitors. (2017) (5)
Design, synthesis and biological evaluation of (1,3-diphenyl-1H-pyrazol-4-yl) methyl benzoate derivatives as potential BRAFV600E inhibitors (2014) (5)
Shikonin derivatives as inhibitors of tyrosyl-tRNA synthetase: design, synthesis and biological evaluation (2016) (4)
Novel 5-(3-(Substituted)-4,5-dihydroisoxazol-5-yl)-2-methoxyphenyl Derivatives : Synthesis and Anticancer Activity (2008) (4)
catena-Poly[[silver(I)-μ-1,2-diaminoethane] hexafluoroarsenate] (2003) (4)
Synthesis, Characterization and Crystal Structures of Monomeric and Imidazolate-Bridged Polymeric Copper(II) Complexes of 5-Methyl-1,5,9-triazanonane (2000) (4)
Synthesis and antimicrobial activities of metal(II) complexes with 2,4-diiodo-6-phenyliminomethyl-phenol (2010) (4)
Aqua[2‐(pyridin‐2‐ylmethyliminomethyl)phenolato‐κ3N,N′,O]copper(II) nitrate monohydrate (2004) (4)
Structure and magnetic properties of a new dinuclear nickel(II) complex with a dinucleating hexaazamacrocycle (1999) (4)
A mononuclear copper(II) compound derived from N-(2-hydroxyethyl)ethylenediamine (2004) (4)
catena‐Poly[[μ‐ethylenediamine‐κ2N:N′‐bis[(ethylenediamine‐κ2N,N′)silver(I)] bis[silver(I)‐μ‐barbiturato‐κ2N:N′]] dihydrate] (2004) (4)
Hydrolysis of 4‐Nitrophenyl Acetate by a μ2‐OH‐bridged Zinc Complex: Crystal Structure of [Zn(oapy)(OAc)(μ2‐OH)] and [ZnL(μ2‐SO4)]4·6H2O (oapy is 2‐aminopyridine and L is 2, 5, 8‐triaza‐1, 9‐di(2‐fluorozenzyl)nonane) (2004) (4)
A fluorescent Rhodol-derived probe for rapid and selective detection of hydrogen sulfide and its application. (2022) (4)
Aqua[N,N′-bis(2-oxidophenylmethyleneimino)-1,3-diaminopropane](thiocyanato)iron(III) (2004) (4)
Synthesis and Biological Evaluation of Dithiobisacetamides as Novel Urease Inhibitors (2021) (4)
Azido[bis(2‐oxidophenylmethyleneimino)propane‐1,2‐diamine(2–)]iron(III) (2004) (4)
Synthesis, crystal structures and insulin-like activity of two new oxidovanadium(V) complexes with aroylhydrazones and maltol mixed-ligands (2017) (4)
Synthesis and Crystal Structure of Bis {2-[(cyclohexylimino)methyl]-4,6-dihydroselenophenol}copper(II) (2010) (4)
Synthesis, structure, and urease inhibitory activities of Co(III), Mn(II) and Zn(II) complexes with hydrazone derived from protocatechuic acid (2016) (4)
A pH-applicative fluorescent probe with long measuring range for monitoring hydrazine in water samples and Arabidopsis thaliana. (2021) (4)
Tris(μ-1,6-diaminohexane)diterephthalatotetrasilver(I) dihydrate (2003) (4)
Diamminesilver(I) picrate (2004) (4)
Study of acylhydrazone derivatives with deoxygenated seven-membered rings as potential β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors (2016) (4)
Identification and Biological Evaluation of Novel Type II B‐RafV600E Inhibitors (2018) (4)
Bis[bis(4-aminopyridine-? N 1 )silver(I)] terephthalate decahydrate (2005) (4)
SYNTHESIS, CHARACTERIZATION AND CRYSTAL STRUCTURES OF OXOVANADIUM(V) COMPLEXES DERIVED FROM SIMILAR AROYLHYDRAZONE LIGANDS (2015) (4)
A versatile nanoplatform based on multivariate porphyrinic metal-organic frameworks for catalytic cascade-enhanced photodynamic therapy. (2021) (4)
Bis(4-aminopyridine)silver(I) trifluoroacetate (2003) (4)
Synthesis, biological evaluation and molecular modeling studies of Schiff bases derived from 4-methylsalicylic acid as potential immunosuppressive agents (2013) (4)
Synthesis, Biological Evaluation, and Docking of Dihydropyrazole Sulfonamide Containing 2‐hydroxyphenyl Moiety: A Series of Novel MMP‐2 Inhibitors (2015) (4)
Ultraviolet irradiation combined with manganese ore catalyzed ozonation of 4-chlorophenol in aqueous solution. (2010) (4)
4,4′‐Dichloro‐2,2′‐[(1E,1′E)‐propane‐1,3‐diylbis(nitrilomethylidyne)]diphenol (2007) (4)
Development of novel chromeno[4,3-c]pyrazol-4(2H)-one derivates containing piperazine as inhibitors of PI3Kα. (2019) (4)
The Research Progress of Direct Thrombin Inhibitors. (2019) (4)
(5,5,7,12,12,14-Hexamethyl-1,4,8,11-tetraazacyclotetradecane-1,8-diacetato)nickel(II) tetrahydrate (2005) (4)
Design, synthesis and biological evaluation of N-phenylsulfonylnicotinamide derivatives as novel antitumor inhibitors. (2012) (4)
Ecosystem threats and management strategies for wetlands in China (2020) (4)
(E)-4-Chlorobenzyl 3-(3-nitrobenzylidene)dithiocarbazate (2009) (4)
Synthesis and Characterization of Ag(I) Salts with Diethylenetriamine. Crystal Structure of [Ag2(dien)2](ClO4)2 (2003) (3)
Recent Progress in Small Molecular Inhibitors of DNA Gyrase. (2021) (3)
The Synthesis and Crystal Determination of 3-Hydroxy-4-(4-methoxyphenyl)-5-(2-nitrophenyl)furan-2(5H)-one (2011) (3)
4-Hydroxy-3-(naphthalen-1-ylmethyl)thiophen-2(5H)-one as inhibitors of tyrosyl-tRNA synthase: Synthesis, molecular docking and antibacterial evaluation (2014) (3)
A three-channel fluorescent probe for selective detection of ONOO- and its application to cell imaging. (2022) (3)
Azido and Thiocyanato-Bridged Polymeric Copper(II) Complexes [CuL(μ1,3-N3)]n·2nH2O and [CuL(μ1,3-NCS)]n: Synthesis and Structures (2013) (3)
Synthesis, characterization and crystal structure of a dioxomolybdenum(VI) complex derived from N’ -(2-hydroxy-4-diethaylaminobenzylidene)-4-hydroxybenzohydrazide (2014) (3)
trans‐Bis{1‐[3‐(cyclohexylamino)propyliminomethyl]‐2‐naphtholato‐κ3O,N,N′}cobalt(III) perchlorate (2004) (3)
Syntheses, Crystal Structures, and Characterization of Copper(II) and Zinc(II) Complexes Derived from N,N-Dimethylethane-1,2-diamine and Phenylacetic Acid Derivatives (2015) (3)
A fluorescent probe derived from benzofuranone for turn-on detection of sulfite in living cells and mice (2022) (3)
Synthesis, crystal structures, and antibacterial evaluation of metal complexes based on functionalized 2-phenylquinoline derivatives. (2014) (3)
Bis[2‐(cyclopropyliminomethyl)phenolato]zinc(II) (2003) (3)
Bis(mu-2-aminopyridine)bis[(trifluoroacetato)silver(I)]. (2004) (3)
Exploiting novel rotors with auxochromic dynamic motors for monitoring lysosomal viscosity (2020) (3)
A highly chromogenic selective Rhodamine-chloride-based fluorescence probe activated by cysteine and application in living cells and zebrafish. (2022) (3)
Imaging the dynamic processes of hydrogen sulfide using a rapid “turn-on” mitochondria-targeting fluorescent probe (2022) (3)
Hexakis(1H-imidazole-?N 3 )cobalt(II) dichloride tetrahydrate (2003) (3)
(1,2-Diaminocyclohexane)silver(I) trifluoromethanesulfonate (2003) (3)
Synthesis and Crystal Structure of a Tetranuclear Zinc(II) Complex Derived from 2-{[1-(4-Diethylamino-2-hydroxy- phenyl)methylidene]amino}-2-ethylpropane-1,3-diol (2013) (3)
(E)-N'-(2-methoxybenzylidene)isonicotinohydrazide dihydrate (2006) (3)
4-Fluorobenzaldehyde picoloylhydrazone (2004) (3)
Synthesis and Crystal Structure of A Mononuclear Copper(II) Complex with 2-[3-(diethylamino)propyliminiomethyl]-5-methoxyphenolate (2010) (3)
Synthesis, biological evaluation and molecular modeling of 1H-benzo[d]imidazole derivatives as novel anti-tubulin polymerization agents (2015) (3)
Acetate anion-selective encapsulation in the ellipsoidal cavity of symmetrical α,α′,δ,δ′-tetramethyl-cucurbit[6]uril (2011) (3)
A high selective colorimetric fluorescent probe for detection of silver ions in vitro and in vivo and its application on test strips. (2022) (3)
Study of Schiff-Base-Derived with Dioxygenated Rings and Nitrogen Heterocycle as Potential β-Ketoacyl-acyl Carrier Protein Synthase III (FabH) Inhibitors. (2017) (3)
Potential ecological risk and speciation analysis of heavy metals in sediments from the Jialu River, China (2017) (3)
Synthesis and Crystal Structure of a 4,4'-bipyridine Linked Dinuclear Copper(II) Complex Derived from 2-{[2-(2-hydroxyethylamino)ethylimino]methyl}-6-methylphenol. (2016) (3)
Syntheses, Characterization, and Crystal Structures of Schiff Base Zinc(II) Complexes With Tetrahedral Coordination (2016) (3)
Polymeric (ethylenediamine)silver(I) 2,4,6‐trinitrophenolate (2003) (3)
Cyclopropyl scaffold: a generalist for marketed drugs. (2020) (3)
Synthesis, characterization, and antibacterial evaluation of copper(II) complexes supported by phenylacetic acid derivatives, and diamine ligands (2014) (3)
Discovery of novel oxoindolin derivatives as atypical dual inhibitors for DNA Gyrase and FabH. (2019) (3)
[N,N′-Bis(salicylidene)-1,3-propanediaminato](methanol)(thiocyanato)nickel(II) (2004) (3)
Discovery of novel pyrazoline derivatives containing methyl-1H-indole moiety as potential inhibitors for blocking APC-Asef interactions. (2020) (3)
The application progress of peptides in drug delivery systems in the past decade (2021) (3)
N-[Methoxy(4-nitrophenyl)methyl]pyridin-2-amine (2007) (3)
The Construction of Halido-Bridged Dinuclear Copper(II) Complexes With Tridentate Schiff Bases (2013) (3)
(Nitrato‐κO)[1‐(pyridin‐2‐ylmethyliminomethyl)naphthalen‐2‐olato‐κO]copper(II) (2004) (3)
Syntheses, Characterization, and Crystal Structures of Bromido-Coordinated Zinc(II) Complexes With Multidentate Schiff Bases (2015) (3)
Bis[tetraamminezinc(II)] tetrapicrate trihydrate (2004) (3)
catena-Poly[[[2,4-dichloro-6-(pyridin-2-ylmethyliminomethyl)phenolato]copper(II)]-mu-thiocyanato]. (2005) (3)
A novel selective probe for detecting glutathione from other biothiols based on the concept of Fluorescence Fusion. (2021) (3)
catena-Poly[[silver(I)-mu-ethane-1,2-diamine-kappa2N:N'] trifluoromethanesulfonate]. (2004) (3)
Corrigendum to Recent progress in the small-molecule fluorescent probes for the detection of sulfur dioxide derivatives (HSO3-/SO32-) [free radical biology and medicine 145 (2019) 42-60/FRB-14407]. (2019) (2)
Synthesis and crystal structures of ethanol-coordinated molybdenum(VI) oxo complexes with tridentate hydrazone ligands. (2013) (2)
Diaquabis(3-hydroxynaphthalene-2-carboxylato-κO)zinc(II) (2004) (2)
A silver(I) complex with Ag⋯Ag interactions: diamminesilver(I) p‐nitrobenzoate (2004) (2)
Microwave Synthesis and Crystal Structure of 2-Hydroxy-3-iodo-benzaldehyde-copper (II) (2011) (2)
catena-Poly[[silver(I)--hexane-1,6-diamine-? 2 N:N'] cinnamate dihydrate] (2004) (2)
Crystal Structure of a Novel Coordination Polymer of 4-Bromobenzoic Acid with Cobalt(II) (2008) (2)
Glutathione-responsive prodrug conjugates for image-guided combination in cancer therapy. (2021) (2)
Bis[2-(o-tolyliminomethyl)phenolato]copper(II) (2005) (2)
Bis(2-aminopyridine-κN1)silver(I) perchlorate (2004) (2)
Synthesis and Crystal Structure of a μ-Oxido-Bridged Dinuclear Iron(III) Complex Derived From 3, 5-Dichlorosalicylaldehyde and 4-(2-Aminoethyl)morpholine (2015) (2)
Improving effect of vegetation on the coastal salt marshes in Yancheng, Eastern China: A five-year observation (2013–2017) (2020) (2)
Syntheses, crystal structures, and antimicrobial activities of nickel(II) and cadmium(II) complexes with 4-methylsulfonyl cinnamate and diamines (2012) (2)
Design, Synthesis, and Pharmacological Investigation of Iodined Salicylimines, New Prototypes of Antimicrobial Drug Candidates (2010) (2)
Synthesis, Characterization and Crystal Structure of Oxovanadium(V) Complex Derived From 2-Bromo-4-chloro-6-((2-(ethylamino)ethylimino)methyl)phenol (2016) (2)
Synthesis, Molecular Modeling and Biological Evaluation of 2‐(Benzylthio)‐5‐aryloxadiazole Derivatives as Antitumor Agents. (2012) (2)
4-Chloro-2-[(E)-(4-fluorophenyl)methyliminomethyl]phenol (2006) (2)
A highly selective AIEgen fluorescent probe for visualizing Cys in living cells and C. elegans (2021) (2)
(E)-Benzyl 3-(3-nitrobenzylidene)dithiocarbazate (2009) (2)
Squaramide-Catalyzed Enantioselective Friedel—Crafts Reaction of Indoles with Imines. (2010) (2)
A new mitochondria-targeted fluorescent probe for exogenous and endogenous superoxide anion imaging in living cells and pneumonia tissue. (2022) (2)
Synthesis, characterization, and biological activities of a Cu(II) complex with the non-steroidal antiinflammatory drug flufenamic acid (2017) (2)
Synthesis and Crystal Structure of a Depside Derivative 2-(2-Methoxy-2-oxoethyl)phenyl 2-(3,4-Dimethoxyphenyl)acetate (2009) (2)
Anagostic C-H⋅⋅⋅Ni interaction and DFT calculation of bis(μ-N,O-((E)-2-((cyclohexylmethylimino)methyl)phenol)–nickel(II) complex (2017) (2)
Fraxinellone (2011) (2)
C-7 modified flavonoids as novel tyrosyl-tRNA synthetase inhibitors (2017) (2)
A novel heterocyclic compound: catena‐poly[[[diaquasodium(I)]‐di‐μ‐aqua] hemi(1,5‐dihydroxy‐4,8,9‐trioxa‐2,6‐diazabicyclo[3.3.1]nona‐2,6‐diene‐3,7‐diolate)]. Retraction (2007) (2)
A novel activatable and switchable nanoaggregate probe for detecting H2S and its application in mice brains. (2020) (2)
Synthesis, Molecular Modeling and Biological Evaluation of 2‐Aminomethyl‐5‐(quinolin‐2‐yl)‐1,3,4‐oxadiazole‐2(3H)‐thione Quinolone Derivatives as Novel Anticancer Agent. (2013) (2)
Nitroimidazole derivatives: a patent review of US 2014/0141084 A1 (2015) (2)
Syntheses and Crystal Structures of Copper(II) and Nickel(II) Complexes With Schiff Bases: Nickel(II) Induced Cleavage of the C–N Bonds (2013) (2)
Phytoremediation for co-contaminated soils of cadmium and pyrene using Phragmites australis (common reed) (2020) (2)
trans-Bis{2-[3-(cyclohexylamino)propyliminomethyl]phenolato}nickel(II) dinitrate (2004) (2)
Synthesis, Characterization, and Crystal Structures of Nickel Complexes Derived from N,N′-Bis(3,5-dichlorosalicylidene)-1,3-pentanediamine and N,N′-Bis(3-methylsalicylidene)-1,2-ethanediamine (2014) (2)
Structure and Antibacterial Activity of 3-(3,4-Dimethoxyphenyl)furan-2(5H)-ones (2012) (2)
Pyridine-2-carboxaldehyde picoloylhydrazone (2004) (2)
Recent Advance in Natural Products with Antiviral Activities. (2021) (2)
Syntheses, characterization, and urease inhibition of oxidovanadium(V) complexes with tridentate hydrazone and bidentate benzohydroxamate ligands (2014) (2)
Poly[disilver(I)(Ag—Ag)-μ-4-chlorobenzoato-μ-piperazine] (2005) (2)
Synthesis and Characterization of Two Novel Fe3(μ 3‐O) Complexes (2006) (2)
Hexaaquanickel(II) bis(p‐nitrobenzoate) dihydrate (2004) (2)
A Self-Supplied O2 versatile nanoplatform for GOx-mediated synergistic starvation and hypothermal photothermal therapy (2022) (2)
A perchlorate salt of 1-{[2-(2-hydroxyethylamino)ethylimino]methyl}naphthalen-2-ol (2005) (2)
Bis[mu-2-[3-(cyclohexylammonio)propyliminomethyl]phenolato]bis[dichlorocopper(II)]. (2004) (2)
COPPER(II) AND ZINC(II) COMPLEXES BASED ON ANTIMICROBIAL DRUG SARAFLOXACIN: SYNTHESIS, STRUCTURE AND BIOLOGICAL EVALUATION (2014) (1)
2‐Nitrobenzaldehyde salicylhydrazone (2004) (1)
Bis(2-aminopyridine-? N 1 )silver(I) hexafluoroarsenate (2004) (1)
Photo‐Degradation of C.I. Disperse Blue 56 by UV Irradiation Combined with Manganese Minerals (2010) (1)
Synthesis, Characterization, and Crystal Structure of [N′-(3-Ethoxy-2-hydroxybenzylidene)-4-fluorobenzohydrazido](quinolin-8-olato)oxovanadium(V) (2016) (1)
Synthesis, characterization and biological evaluation of naproxen Cu(II) complexes (2019) (1)
Synthesis and Characterization of Ni(II) Chelate with Schiff Base Ligands Derived from S‐hydrazyldithiocarbazate and p‐dibutylaminobenzaldehyde (2006) (1)
The Unexpected Synthesis, Crystal Structure, and Thermal Stability of a Copper(II) Complex Derived from 2-[(2-Phenylaminoethylimino)methyl]benzoic Acid (2013) (1)
Bis(μ-4-chlorobenzoato-κ2O:O)bis[(2-aminopyridine-κN)silver(I)] (2004) (1)
Synthesis and Crystal Structure of a Rarely Seen Terephthalato-Bridged Dinuclear Copper(II) Complex [Cu2(CMP)2(TPA)]·[Cu2(CMP)2(MeOH)2(TPA)]·2H2O (2013) (1)
trans-Bis{2-[3-(cyclohexylamino)propyliminomethyl]naphtholato}cobalt(III) perchlorate (2004) (1)
[N,N′‐Bis(2‐hydroxynaphthylmethylene)‐1,3‐propanediaminato]cobalt(II) (2004) (1)
Salicylideneacetone (2005) (1)
Bis(4‐maleimidophenyl)methane (2003) (1)
Crystal structure of (E)-2-fluoro-6-((4-hydroxyphenethylimino)- methyl)phenol, C15H14FNO2 (2009) (1)
Bis(2-aminopyridine)bis(4-fluorobenzoato)cadmium(II) (2003) (1)
Artificial Intelligence and Cheminformatics-guided Modern Privileged Scaffold Research. (2021) (1)
Aqua(pyridine-κ N )( N -salicylideneglycinato-κ 3 N , O , O ′)copper(II) (2005) (1)
(E)-N '-(3-Bromobenzylidene)isonicotinohydrazide (2006) (1)
Design and synthesis of a novel series of N,4-diphenylpyrimidin-2-amine derivatives as potent and selective PI3Kγ inhibitors (2014) (1)
(5,5,7,12,12,14‐Hexamethyl‐1,4,8,11‐tetraazacyclotetradecane‐1,8‐diacetato)cobalt(II) tetrahydrate (2005) (1)
-Piperidine-? 2 N : N '-bis[(3-nitrobenzoato-? O )silver(I)] monohydrate (2005) (1)
2-[(4-Bromophenylimino)methyl]-4,6-diiodophenol (2012) (1)
catena-Poly[[silver(I)-μ-tris(2-aminoethyl)amine-κ4N,N′,N′′:N′′′] perchlorate] (2005) (1)
Solvolthermal Synthesis and Crystal Structure of a Polymeric Copper Complex With 5-Methyltetrazolate Ligands (2013) (1)
Bis(μ-4-chlorobenzoato-κ2O:O′)bis[(2-aminopyridine-κN)silver(I)](Ag—Ag) monohydrate (2004) (1)
Synthesis, Characterization, and Crystal Structure of a Dinuclear Cadmium(II) Complex Derived From 4-Chloro-2-{[2-(2-Hydroxyethylamino)Ethylimino]Methyl}Phenol (2014) (1)
2‐Methoxy‐5‐nitrobenzene‐1,3‐diyl bis(benzenesulfonate) (2007) (1)
Crystal structure of 2[(4-fluorophenylimino)methyl]-4,6-diiodophenol, C13H8FI2NO (2012) (1)
{2-[(1,5-Dimethyl-2-phenyl-3-oxo-2,3-dihydro-1H-pyrazol-4-ylimino)methyl]phenoxy}acetic acid methanol hemisolvate (2004) (1)
Synthesis, Characterization, and Cytotoxic Properties of Platinum(II)‐Amine Complexes. X‐ray Crystal Structure Determination of [Pt(C6H12N4)Cl2] · 3H2O (2006) (1)
Bis(μ-4-chlorobenzoato-κ2O:O)bis-[(2-amlnopyridine-κN)silver(I)] (2004) (1)
Bis(2-aminopyridine-? N 1 )bis(2-fluorobenzoato-? O )zinc(II) (2004) (1)
2‐Nitrobenzaldehyde picoloylhydrazone (2004) (1)
catena‐Poly[[silver(I)‐μ‐propane‐1,3‐diamine‐κ2N:N′] bis(4‐nitrobenzoato‐κO)argentate(I)] (2005) (1)
(E)‐4‐Chloro‐2‐[(cyclopentylimino)methyl]phenol (2007) (1)
Introducing Broadened Antibacterial Activity to Rhodanine Derivatives Targeting Enoyl-Acyl Carrier Protein Reductase. (2019) (1)
[N,N′‐Bis(2‐hydroxynaphthylmethenylimino)‐1,2‐ethanediaminato]cobalt(II) (2004) (1)
Tetrakis{μ‐1‐[2‐(2‐oxidoethylamino)ethyliminomethyl]‐2‐naphtholato}tetrazinc(II) (2004) (1)
Navigating into the chemical space between MGCD0103 and SAHA: novel histone deacetylase inhibitors as a promising lead (2015) (1)
Bis{2‐[3‐(diethylamino)propyliminomethyl]phenolato}copper(II) diperchlorate (2004) (1)
Reactivity Modes of Cp*M-Type Half-Sandwich Dichalcogenolate Complexes with 2,6-Disubstituted Aryl Azides: The Effects of the Metal Center, Chalcogen, and Ligand Moiety on Product Formation (2019) (1)
A novel heterocyclic compound: catena-poly[[[diaquasodium(I)]-di-mu-aqua] hemi(1,5-dihydroxy-4,8,9-trioxa-2,6-diazabicyclo[3.3.1]nona-2,6-diene-3,7-diolate)]. (2007) (1)
Synthesis, Characterization, and Crystal Structures of New Oxovanadium(V) Complexes With Mixed Nicotinohydrazone and 8-Hydroxyquinoline Ligands (2016) (1)
A butterfly‐shaped Schiff base complex: bis[2‐(cyclopropyliminiomethyl)naphthalato]dithiocyanatozinc(II) (2004) (1)
5,7-Dimethoxy-3-(4-methoxyphenyl)-4H-chromen-4-one (2007) (1)
A fluorescent probe for monitoring sulfite in living cells with large Stokes shift and rapid response. (2022) (0)
Isolation and Identification of a Phenol-Degrading Yeast JP-1 with High Activity and Its Degrading Characteristics and Kinetic (2014) (0)
N,N′‐Bis(3,4‐dimethoxybenzylidene)ethylenediamine (2006) (0)
Identification of (N-aryl-N-arylsulfonyl)aminoacetohydroxamic acids as novel urease inhibitors and the mechanism exploration. (2022) (0)
The Promising Enzymes for Inhibitors Development against COVID-19. (2021) (0)
Schiff’s base derivatives bearing 2-thiophenoxyquinoline nucleus as new antibacterial agents (2013) (0)
1,4,8,11‐Tetrakis(carboxymethyl)‐5,5,7,12,12,14‐hexamethyl‐1,4,8,11‐tetraazoniacyclotetradecane tetrachloride octahydrate (2005) (0)
Crystal structure of 2-(2,3-dihydrobenzo[1,4]dioxin-6-yl)-5-(4-nitro benzylsulfanyl)-[1,3,4]oxadiazole, C17H13N3O5S (2012) (0)
Crystal structures of azido or thiocyanato-coordinated nickel(II) complexes with tridentate Schiff bases (2013) (0)
Discovery of novel 1,3-diaryl pyrazolyl ester derivatives as COX-2 inhibitory candidates with anti-tumor effect (2022) (0)
trans-Bis{1-(3-(cyclohexylamino)propylimino- methyl)-2-naphtholato-j3O,N,N000}cobalt(III) perchlorate (2004) (0)
SYNTHESIS, CRYSTAL STRUCTURES AND MAGNETIC PROPERTIES OF TWO METHOXO-BRIDGED DIMERIC (2002) (0)
Catena-poly[[silver(I)-mu-hexane-1,6-diamine-kappa2N:N'] cinnamate dihydrate]. (2004) (0)
EGFR-binding peptide: a patent evaluation of WO2014002836 (2014) (0)
3-(4-Acetoxyphenyl)-4-oxo-4H-1-benzopyran-5,7-diyl diacetate (2009) (0)
Crystal structure of 1-(2-methyl-5-nitroimidazol- 1-yl)propane-2-thiol, C7H11N3O2S (2011) (0)
Tetrakis(diethylenetriammonium) tris[hexacyanoferrate(II)] octahydrate (2006) (0)
2-[(2-Chlorophenyl)iminomethyl]-4,6-diiodophenol (2012) (0)
Efficient Method for the Synthesis of Tectorigenin (VI). (2008) (0)
1,3-Bis(2-furylmethylidene)-3,4,5,6-tetrahydropyrimidin-2(1H)-one (2004) (0)
Correction: Discovery of fluoroquinolone derivatives as potent, selective inhibitors of PI3Kγ (2015) (0)
Methyl 5‐hydroxy‐2‐(2‐hydroxy‐6‐methoxy‐4‐methylbenzoyl)‐3‐methoxybenzoate (2005) (0)
(μ‐Biphenyl‐4,4′‐dicarboxylato)bis[(2‐aminopyridine)silver(I)] (2004) (0)
Group-assisted Purification (GAP) Chemistry/Technology in Synthesizing the Chiral Intermediate of Rivastigmine and Its α-Alkyl Benzylamine Analogues (2019) (0)
trans‐Bis{2‐[3‐(cyclohexylamino)propyliminomethyl]phenolato‐κ3O,N,N′}cobalt(III) perchlorate (2003) (0)
Synthesis, structure, and biological assay of cinnamic amides as potential EGFR kinase inhibitors (2012) (0)
Development and Challenges of the Discovery of HER2 Inhibitors (2021) (0)
2,4-Bis(2-bromophenyl)-1,3-bis(3-nitrobenzoyl)cyclobutane (2006) (0)
Base- and Copper-Catalyzed Intramolecular Cyclization for the Direct Synthesis of Dihydrofurans. (2010) (0)
catena-Poly[[silver(I)-micro-ethane-1,2-diamine-kappa(2)N:N'] 3-fluorobenzoate monohydrate]. (2004) (0)
Correction: A highly selective AIEgen fluorescent probe for visualizing Cys in living cells and C. elegans (2022) (0)
Synthesis, characterization, and crystal structures of oxidovanadium(V) complexes derived from similar hydrazone and benzohydroxamate mixed ligands (2017) (0)
2,4-Diiodo-6-[(propylimino)methyl]phenol (2012) (0)
1,5-Bis(4-chlorophenyl)-3-(4-pyridyl)pentane-1,5-dione (2006) (0)
Vanillin derivatives as the selective small molecule inhibitors of FtsZ (2013) (0)
One‐Pot Synthesis of Indene Derivatives by CF3SO3H‐Promoted Reactions of Benzylic Alcohols and 1,3‐Dicarbonyl Compounds. (2013) (0)
Corrigendum: An Activatable and Switchable Nanoaggregate Probe for Detecting H2 S and Its Application in Mice Brains. (2021) (0)
cyclo-Tetrakis{μ-1-[2-(2-oxidoethylamino)ethyliminomethyl]naphthalen-2-olato}tetranickel(II) (2005) (0)
2-(1-Naphthyliminomethyl)phenol (2006) (0)
catena-Poly[[[mu-pyrazine-kappa2N:N'-disilver(I)]-di-mu-pyrazine-kappa4N:N'] bis(trifluoromethanesulfonate) dihydrate]. (2004) (0)
Poly[silver(I)- 2 -2-methylpyrazine- 2 -trifluoroacetato], a reinvestigation (2004) (0)
1,2,3,5a,6,11,12,14a‐Octahydro‐9‐methoxy‐12‐(2‐methylprop‐1‐enyl)‐5H,14H‐pyrrolo[1′′,2′′:4′,5′]pyrazino[1′,2′:1,6]pyrido[3,4‐b]indole‐5,14‐dione (2006) (0)
catena -Poly[[aquadicinnamatocadmium]--1,4-diazabicyclo[2.2.2]octane] (2005) (0)
catena -Poly[[aquanitritosilver(I)]--1,4-diazabicyclo[2,2,2]octane-? 2 N:N '] (2004) (0)
Synthesis, molecular modeling, and biological evaluation of 1,2,4-triazole derivatives containing pyridine as potential anti-tumor agents (2012) (0)
Benzene‐1,2,3‐triyl tris(benzenesulfonate) (2007) (0)
Constructing a novel fluorescence detection method for γ-glutamyltranspeptidase and application on visualizing liver injury. (2022) (0)
Synthesis and Antiproliferative Activity of Multisubstituted N-Fused Heterocycles Against the Hep-G2 Cancer Cell Line. (2011) (0)
Corrigendum to "Synthesis, crystal structures, molecular docking, and in vitro biological activities evaluation of transition metal complexes with 4-(3,4-dichlorophenyl) piperazine-1-carboxylic acid" [J. Mol. Struct. 1117 (2016) 293-299] (2016) (0)
Imaging of a novel ratio γ-glutamyl transpeptidase fluorescent probe in living cells and biopsies. (2023) (0)
Crystal structure of (E)-2-fluoro-6-((4-hydroxyphenethylimino)- methyl)phenol, C15H14FNO2 (2009) (0)
Targeted antimicrobial moieties (WO2010080819): patent evaluation (2011) (0)
Synthesis, biological evaluation and molecular modeling studies of Schiff bases derived from 4-methylsalicylic acid as potential immunosuppressive agents (2013) (0)
Development and Challenges of HER2 Inhibitors Discovery. (2020) (0)
catena-Poly[1,4-diazoniabicyclo[2.2.2]octane [silver(I)-tri-mu-thiocyanato-kappa6S:S]]. (2004) (0)
Effects of landscape on the distributions of nutrients and polycyclic aromatic hydrocarbons in an urban river system (2019) (0)
Crystal Structure of a Novel Coordination Polymer of 2-Hydroxy-N′-(propan-2-ylidene)benzohydrazide with Cadmium(II) (2008) (0)
onoids as novel tyrosyl-tRNA synthetase inhibitors † (2017) (0)
Supramolecular Architecture of Two 4-(Methylsulfonyl) Benzaldehyde Schiff Bases (2012) (0)
Syntheses and Structures of a Pair of Isologous Complexes: ZnLCl2 and ZnLBr2 (2014) (0)
3-(tert-Butoxycarbonyl)-2-(4-chlorophenyl)-1,3-thiazolidine-4-carboxylic acid. Corrigendum (2010) (0)
Meet Our Executive Guest Editor (2019) (0)
TWO WATER-COORDINATED MONONUCLEAR MOLYBDENUM(VI) OXO COMPLEXES WITH SIMILAR TRIDENTATE HYDRAZONE LIGANDS: SYNTHESIS AND CRYSTAL STRUCTURES (2013) (0)
Direct Synthesis of Nitriles from Aldehydes Using Chloramine‐T/KI in Aqueous Ammonia. (2014) (0)
{2‐[(1,5‐Dimethyl‐3‐oxo‐2‐phenyl‐2,3‐dihydro‐1H‐pyrazol‐4‐ylimino)methyl]phenoxy}acetic acid nitrate (2003) (0)
Diaqua(2,2′‐bipyridyl)(2,2′‐dihydroxy‐[1,1′]‐binaphthalene‐3,3′‐dicarboxylato)cadmium(II) N,N‐dimethylformamide solvate (2004) (0)
3-(3-Hydroxyphenyl)-1-(4-nitrophenyl)prop-2-en-1-one (2006) (0)
Vanadium(V) Complexes Derived from N'-(3-Bromo-2-hydroxybenzylidene)-2-methylbenzohydrazide and N'-(3-Bromo-2-hydroxybenzylidene)-2-methoxybenzohydrazide: Syntheses and Structures (2016) (0)
Efficient and Highly Enantioselective Michael Addition of Aldehydes to Nitroalkenes Catalyzed by a Surfactant-Type Organocatalyst in the Presence of Water. (2010) (0)
Synthesis and Crystal Structures of Co(maa)2(H2O)2 and Cu(maa)2(H2O)2, where maaH is 2‐Methoxyacetatic Acid (2005) (0)
Activity-Based Imaging of Macrophage Migration Inhibitory Factor with a Two-Photon Fluorescent Probe. (2022) (0)
Photoacoustic spectroscopic study on a pair of hydrate isomers for dinuclear copper(II) complexes with a 26-membered hexaazamacrocycle (1999) (0)
(E)-4-[(3,5-Dimethylphenyl)iminomethyl]-2-methoxy-3-nitrophenol (2011) (0)
SYNTHESIS, PHARMACOLOGICAL EVALUATION AND MOLECULAR DOCKING STUDY OF TRIAZOLES CHIFF BASE DERIVATIVES CONTAINING1, 4-BENZODIOXAN MOIETYAS NOVEL JAK INHIBITORS (2014) (0)
Synthesis, biological evaluation, and molecular docking studies of pyrazolyl-acylhydrazone derivatives as novel anticancer agents (2014) (0)
Mechanism of cyanobacterial bloom control by magnetic lanthanum-based material. (2022) (0)
μ‐2‐Methylpyrazine‐μ‐trifluoroacetato‐silver(I) (2004) (0)
Syntheses, characterization, and crystal structures of 4-methyl-2-(naphthalen-1-yliminomethyl)phenol and its cobalt(III) complex (2017) (0)
7‐Methoxy‐3‐(4‐methoxyphenyl)‐4‐oxo‐4H‐chromen‐5‐yl acetate (2007) (0)
Notice of RetractionMicrowave Intensified and Regenerated Iron Chippings/Coconut-Shell Activated Carbon System to Degrade Reactive Brilliant Red K-2BP in Water (2011) (0)
A Hypoxia-Activated Red-Emission Fluorescent Probe for in Vivo Imaging in Tumor Microenvironment and for Tumor Inhibition (2022) (0)
Meet Our Associate Editor (2018) (0)
Hexaaquanickel(II) dichloride bis(hexamethylenetetramine) tetrahydrate (2003) (0)
Synthesis, evaluation and mechanism exploration of 2-(N-(3-nitrophenyl)-N-phenylsulfonyl)aminoacetohydroxamic acids as novel urease inhibitors. (2022) (0)
SYNTHESIS AND ANTIBACTERIAL ACTIVITIES EVALUATION OF WATER-SOLUBLE CAFFEIC ACID AMMONIUM SALTS (2010) (0)
The Construction of a Novel Bromido- and Azido-Bridged Dinuclear Copper(II) Complex Derived From 4-Chloro-2-[(2-hydroxyethylimino)methyl]phenol (2013) (0)
catena‐Poly[[di‐μ‐benzoato‐κ4O:O′‐disilver(I)]‐μ‐N,N′‐bis(2‐fluorobenzylidene)butane‐1,4‐diamine‐κ2N:N′] (2004) (0)
Bis[N,N′-bis(2-fluorobenzylidene)ethylenediamine-κ2N,N′]silver(I) nitrate (2003) (0)
1-{2-[(4-Chlorobenzylidene)amino]phenyl}-3-phenylthiourea (2012) (0)
CCDC 821674: Experimental Crystal Structure Determination (2012) (0)
Structure-based Discovery of Novel Antibacterials (2010) (0)
PROTECTIVE ACTION OF THE GENISTEIN DERIVATIVE IN GASTRIC ULCER PREVENTION INDUCED BY ETHANOL IN RATS (2014) (0)
A Colorimetric and Fluorescent Probe for Selective Detection of Silver Ions in vitro and in vivo (2021) (0)
catena-Poly[[silver(I)--1,4-diaminobutane-? 2 N:N'] hexafluoroarsenate] (2003) (0)
(E)-Ethyl 3-(2-fluoroanilino)-2-(4-methoxyphenyl)acrylate (2008) (0)
N,N′‐Bis(3‐nitrobenzylidene)‐trans‐1,2‐cyclohexanediamine (2005) (0)
CCDC 747817: Experimental Crystal Structure Determination (2010) (0)
Two birds with one stone: a NIR fluorescent probe for mitochondrial protein imaging and its application in photodynamic therapy. (2021) (0)
Meet Our Associate Board Member (2018) (0)
EGFR/HER‐2 Inhibitors: Synthesis, Biological Evaluation and 3D‐QSAR Analysis of Dihydropyridine‐Containing Thiazolinone Derivatives. (2015) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Hai‐liang Zhu?

Hai‐liang Zhu is affiliated with the following schools:

Nanjing University
Wuhan Textile University
Lanzhou University

Hai‐liang Zhu's Academic­Influence.com Rankings

Hai‐liang Zhu's Degrees

Why Is Hai‐liang Zhu Influential?

Hai‐liang Zhu's Published Works

Published Works

What Schools Are Affiliated With Hai‐liang Zhu?

Hai‐liang Zhu's AcademicInfluence.com Rankings